# Chapter 39: Generalized Anxiety Disorder

Here is the comprehensive academic chapter on the biological and neurological basis of Generalized Anxiety Disorder, citing exclusively from the 2000 research papers provided.

## **The Biological and Neurological Basis of Generalized Anxiety Disorder**

## Introduction

Generalized Anxiety Disorder (GAD) is one of the most common and debilitating mental health conditions, affecting a significant portion of the adult population each year (Munir & Takov, 2021; Munir et al., 2021). It is a chronic and pervasive illness (Szkodny et al., 2014) defined by a core feature of excessive, persistent, and uncontrollable worry about a multitude of everyday events and activities, such as work, school performance, finances, family, and health (Munir & Takov, 2021; Treanor & Roemer, 2010; Szkodny et al., 2014). This apprehensive expectation of future misfortunes (Gautam et al., 2017) must persist for at least six months and is accompanied by a constellation of non-specific but distressing psychological and physical symptoms (Munir et al., 2021). These associated symptoms include restlessness or feeling 'keyed up or on edge,' being easily fatigued, difficulty concentrating or the mind going blank, irritability, muscle tension, and significant sleep disturbance, such as difficulty falling or staying asleep (Munir & Takov, 2021; Szkodny et al., 2014; Treanor & Roemer, 2010; Mandos et al., 2009).

The impact of GAD on an individual's life is substantial, causing clinically significant distress and marked impairment in social, occupational, and other important areas of functioning (Szkodny et al., 2014; Munir, 2021). The level of disability associated with GAD is comparable to that of major depressive disorder (MDD) (Szkodny et al., 2014). This is compounded by the disorder's high degree of comorbidity with other psychiatric conditions, most notably MDD, but also panic disorder, social anxiety disorder, and substance use disorders (Pollack, 2001; Ninan, 2001; Szkodny et al., 2014). This overlap in symptomatology, particularly with depression, often complicates diagnosis and treatment (Vanin, 2008; Tollefson et al., 1993). Symptoms such as fatigue, sleep disturbance, anxiety, and neurocognitive dysfunction are common to both GAD and MDD, suggesting a potential shared underlying pathophysiology (Kennedy, 2008; Vanin, 2008).

While psychological and social factors are undeniably crucial in the development and maintenance of GAD (Bamalan et al., 2023), a growing body of evidence points toward a complex biological and neurological foundation. The disorder is not merely a reaction to life circumstances but is understood to arise from a multifaceted interplay of genetic predisposition, neurochemical imbalances, neuroendocrine dysregulation, and altered neural circuitry (Ninan, 2001; Bamalan et al., 2023). The effectiveness of specific pharmacological and psychological interventions provides crucial clues into these underlying mechanisms (Kavan et al., 2009; Allgulander & Baldwin, 2013). This chapter aims to provide a comprehensive overview of the biological and neurological basis of GAD, synthesizing findings from the available literature. We will explore the roles of neurotransmitter systems, stress-response circuits, genetic influences, and brain structure and function. By examining these biological underpinnings, we can gain a more complete understanding of the disorder's etiology, its chronic and debilitating course (Szkodny et al., 2014), and the rationale for current and future therapeutic strategies. It is critical, however, to acknowledge that our understanding is still evolving, and GAD likely represents a heterogeneous condition with diverse biological contributors (Bamalan et al., 2023; Szkodny et al., 2014).

## Neurobiological Systems

The persistent state of worry, hypervigilance, and somatic tension characteristic of GAD is thought to be rooted in the dysregulation of several key neurobiological systems. These systems, responsible for processing threats, regulating stress responses, and maintaining emotional homeostasis, appear to be in a state of chronic hyperactivity in individuals with GAD. The evidence, largely drawn from neuropharmacology and the clinical presentation of the disorder, points to significant disturbances in neurotransmitter pathways, the neuroendocrine stress axis, and the autonomic nervous system.

### Neurotransmitter Systems and Neuropharmacology

The efficacy of psychotropic medications in alleviating the symptoms of GAD provides a critical window into the neurochemical underpinnings of the disorder (Allgulander & Baldwin, 2013; Valente, 1996). The primary systems implicated are the serotonergic, noradrenergic, and GABAergic pathways, which are integral to the regulation of mood, arousal, and anxiety.

**The Serotonergic System:** A wealth of evidence points to the central role of serotonin (5-hydroxytryptamine, or 5-HT) in the pathophysiology of GAD. The first-line pharmacological treatment for GAD includes selective serotonin reuptake inhibitors (SSRIs) (Allgulander & Baldwin, 2013; Gautam et al., 2017; Valente, 1996). These medications, which include agents like fluoxetine, paroxetine, and sertraline, function by blocking the reuptake of serotonin at the synapse, thereby increasing its availability (Rosenbaum & Zajecka, 1997; Chouinard & Chouinard, 2015). The therapeutic success of SSRIs in reducing both the psychic symptoms of worry and the somatic symptoms of anxiety strongly implies that a dysregulation or relative deficiency in serotonergic transmission is a key component of GAD (Allgulander & Baldwin, 2013). The fact that SSRIs are also first-line treatments for major depression highlights a potential shared neurobiological vulnerability between GAD and depressive disorders, which frequently co-occur (Pollack, 2001; Kennedy, 2008). The serotonin system is known to be involved in modulating mood, sleep, and appetite (Kennedy, 2008), all of which are disrupted in GAD (Munir & Takov, 2021). The combination of serotonergic agents, such as an SSRI with a monoamine oxidase inhibitor (MAOI), can lead to serotonin syndrome, a potentially life-threatening condition characterized by mental status changes, autonomic stimulation, and neuromuscular excitation, further underscoring the powerful role of this neurotransmitter system (Gordon & Leder, 2012; Bismuth et al., 1980).

**The Noradrenergic System:** The noradrenergic system, originating primarily in the locus coeruleus, is fundamental to the body's "fight-or-flight" response and is closely linked to states of arousal, vigilance, and anxiety (McCann & Kain, 2001; Emmett et al., 2019). The efficacy of serotonin-norepinephrine reuptake inhibitors (SNRIs), such as venlafaxine, as a first-line treatment for GAD points to the involvement of norepinephrine in its pathophysiology (Allgulander & Baldwin, 2013; Gautam et al., 2017). Many of the somatic symptoms of GAD, including palpitations, tachycardia, sweating, and restlessness, are manifestations of autonomic overactivity (Gautam et al., 2017), which is driven by the sympathetic nervous system and its primary neurotransmitter, norepinephrine (Ali et al., 2018). It is hypothesized that in GAD, the noradrenergic system is in a state of chronic overactivation, contributing to the persistent feelings of being "on edge" and physically tense (Gautam et al., 2017; Munir & Takov, 2021). Stressful events, which are known triggers for anxiety, lead to the release of catecholamines, including norepinephrine, further implicating this system in the disorder's expression (Chu et al., 2019; Bhatt, 2014).

**The GABAergic System:** Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system, acting as a "brake" on neuronal excitability. A deficiency in GABAergic function is a long-standing hypothesis for the biological basis of anxiety (van Praag, 1998). This is supported by the anxiolytic effects of benzodiazepines, which act by enhancing the effect of GABA at the GABA-A receptor, thereby promoting inhibition and reducing neuronal firing (Valente, 1996; Gautam et al., 2017). While effective for short-term relief of acute anxiety, the long-term use of benzodiazepines in GAD is discouraged due to risks of dependence, tolerance, and withdrawal symptoms (Rangaraj & Pélissolo, 2006; Bismuth et al., 1980). Nonetheless, their mechanism of action provides strong evidence for the involvement of the GABAergic system in the modulation of anxiety. It is theorized that individuals with GAD may have a deficit in GABAergic tone, leading to a state of disinhibition in brain circuits responsible for generating fear and worry (van Praag, 1998).

### The Neuroendocrine Stress Axis (HPA Axis)

GAD is fundamentally a disorder of chronic stress and worry (Munir & Takov, 2021). The body's primary system for managing stress is the hypothalamic-pituitary-adrenal (HPA) axis (Chu et al., 2019; Vinkers et al., 2021). In response to a perceived threat, the hypothalamus releases corticotropin-releasing hormone (CRH), which stimulates the pituitary gland to release adrenocorticotropic hormone (ACTH). ACTH, in turn, signals the adrenal glands to release cortisol, the primary stress hormone (McCann & Kain, 2001; Silverman & Deuster, 2014). This cascade prepares the body to handle challenges (Bhatt, 2014).

In healthy individuals, this system is tightly regulated by a negative feedback loop, where cortisol inhibits further release of CRH and ACTH, allowing the system to return to homeostasis once the stressor has passed (Vinkers et al., 2021). In chronic stress conditions, such as GAD, this system is thought to become dysregulated (Pervanidou & Chrousos, 2018; Vinkers et al., 2021). The constant worry and apprehensive expectation in GAD may lead to a sustained activation of the HPA axis (Chu et al., 2019). This chronic hyperarousal state is believed to contribute to many of the disorder's symptoms, including fatigue, sleep disturbances, and difficulty concentrating (Kennedy, 2008; Szkodny et al., 2014). Prolonged exposure to elevated cortisol levels can have widespread detrimental effects on the body and brain, potentially contributing to the high rates of medical comorbidity seen in patients with chronic anxiety (Vinkers et al., 2021; Pervanidou & Chrousos, 2011). Indeed, dysregulation of the HPA axis is a common finding across both depressive and anxiety disorders, suggesting it may be a shared biological pathway underlying these frequently comorbid conditions (Vinkers et al., 2021).

### The Autonomic Nervous System

The autonomic nervous system (ANS) regulates involuntary bodily functions and is composed of the sympathetic (arousing) and parasympathetic (calming) branches (McCann & Kain, 2001). The "fight-or-flight" response is mediated by the sympathetic nervous system (SNS), leading to physiological changes such as increased heart rate, sweating, and muscle tension (Michie, 2002). Many of the defining physical symptoms of GAD are direct manifestations of "autonomic overactivity" or a hyperactive SNS (Gautam et al., 2017; Munir & Takov, 2021). Symptoms such as palpitations, tachycardia, excessive sweating, trembling, and dry mouth are all hallmarks of sympathetic arousal (Ali et al., 2018; Gautam et al., 2017).

In GAD, the ANS appears to be in a state of chronic imbalance, with a persistent dominance of sympathetic tone over parasympathetic tone (Emmett et al., 2019). This contributes to the physical feelings of being constantly "keyed up" or "on edge" and the pervasive muscle tension reported by patients (Szkodny et al., 2014). This state of hyperarousal is not only subjectively distressing but also places a significant physiological load on the body, which may contribute to the profound sense of fatigue that is also a core criterion of the disorder (Munir & Takov, 2021; Kennedy, 2008). The locus coeruleus, the brain's principal site for norepinephrine synthesis, is a key hub in the central autonomic network and plays a critical role in regulating this arousal state, linking the noradrenergic neurotransmitter system directly to the physical experience of anxiety (Emmett et al., 2019).

## Genetic and Molecular Basis

While environmental factors and life experiences are significant triggers for GAD, it is widely recognized that they act upon a substrate of individual biological vulnerability (Bamalan et al., 2023). This vulnerability is shaped by a complex interplay of genetic and molecular factors that influence the development and function of the very neurobiological systems discussed previously. The evidence for a genetic contribution to GAD comes from family and twin studies, which demonstrate that the disorder aggregates within families, while molecular research is beginning to explore the pathways that translate this genetic risk into clinical psychopathology.

### Genetic Factors and Heritability

Anxiety disorders, including GAD, tend to run in families, suggesting a significant genetic component to their etiology (Ninan, 2001; Bagnell, 2011). Individuals with a family history of anxiety or mood disorders are at an increased risk of developing GAD themselves (Ninan, 2001; Hildawati, 2021). This familial aggregation points to a heritable predisposition, although it does not disentangle the effects of shared genes from shared environments (Ninan, 2001). However, the etiology of GAD is understood to be multifactorial, arising from a complex interaction between this genetic predisposition and various environmental, psychological, and biological factors (Bamalan et al., 2023; Koo, 2018; Du, 2013).

Life events, particularly those that are stressful or traumatic, are potent environmental triggers that can unmask a latent genetic vulnerability (Pervanidou & Chrousos, 2018; Casey & Bailey, 2011). For instance, experiences of childhood adversity or abuse can have long-lasting effects on the developing brain, potentially altering gene expression through epigenetic mechanisms and increasing the risk for anxiety disorders in adulthood (van der Kolk, 1998; Bouras & Lazaratou, 2012). Therefore, GAD is not determined by a single gene but is likely a polygenic disorder, where many genes of small effect combine to increase an individual's susceptibility (Ninan, 2001). These genes are thought to influence the functioning of neurotransmitter systems and the regulation of the stress response (van Praag, 1998; Vinkers et al., 2021).

### Molecular Mechanisms

Although the specific genes contributing to GAD risk are not fully elucidated in the provided literature, the mechanisms of action of effective treatments offer clues to the molecular pathways involved. The efficacy of SSRIs and SNRIs strongly suggests that genes related to the serotonin and norepinephrine systems—such as those coding for transporters, receptors, and synthesizing enzymes—are prime candidates (Allgulander & Baldwin, 2013). Variations in these genes could lead to subtle differences in neurotransmitter function, predisposing an individual to the kind of neurochemical imbalance seen in anxiety disorders. Similarly, the role of the GABAergic system, highlighted by the action of benzodiazepines, suggests that genes related to GABA-A receptors are also likely involved (Valente, 1996).

Beyond neurotransmitter systems, molecular pathways related to the stress response are of critical importance. The HPA axis and the sympathetic nervous system are central to the experience of stress and anxiety (Chu et al., 2019; Vinkers et al., 2021). Genetic variations could influence the reactivity of these systems, making some individuals more sensitive to stressors (Pervanidou & Chrousos, 2011; Silverman & Deuster, 2014).

Furthermore, there is an emerging understanding of the role of the immune system and inflammation in psychiatric disorders, particularly depression, which is highly comorbid with GAD (Anisman et al., 2005). Chronic stress, a hallmark of GAD, can lead to a state of low-grade systemic inflammation, characterized by elevated levels of pro-inflammatory cytokines like interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) (Anisman & Merali, 2003; Kiecolt-Glaser et al., 2015). These cytokines can cross the blood-brain barrier and influence neurotransmitter metabolism and neuroendocrine function, thereby contributing to symptoms of fatigue, anhedonia, and anxiety (Anisman et al., 2005). This suggests that genes regulating the immune response may also play a role in the vulnerability to GAD, perhaps by modulating an individual's inflammatory response to psychological stress (Vinkers et al., 2021). This link between the immune system, stress, and mood provides a compelling molecular bridge between the psychological experience of worry and the physical symptoms of fatigue and malaise that define GAD (Kennedy, 2008).

## Brain Structure and Function

The persistent worry, hyperarousal, and cognitive symptoms of GAD are thought to reflect dysfunction within specific neural circuits that regulate emotion, threat detection, and executive control. While the available literature does not provide direct neuroimaging studies of GAD, findings from related anxiety and mood disorders, combined with an understanding of functional neuroanatomy, allow for the formulation of a compelling neurobiological model of the disorder. This model centers on a disturbed interplay between limbic structures responsible for generating fear and anxiety, and prefrontal cortical regions tasked with their top-down regulation.

### Brain Regions and Neural Circuits

**The Amygdala and Limbic System:** The amygdala, a key component of the limbic system, is centrally involved in processing fear and threat-related stimuli (Emmett et al., 2019; Anderson, 2007). It acts as a "threat detector," rapidly appraising the environment for potential danger and initiating a cascade of physiological and behavioral responses, including activation of the HPA axis and the autonomic nervous system (Emmett et al., 2019; Anderson, 2007). In anxiety disorders, the amygdala is believed to be hyperactive, showing an exaggerated response to both threatening and ambiguous or neutral stimuli (Mathews & MacLeod, 1994). This hyperactivity could underlie the core GAD feature of "apprehensive expectation" (Szkodny et al., 2014), where individuals scan their environment for potential danger and interpret neutral situations as threatening (Mathews & MacLeod, 1994). The amygdala's dense connections to the hypothalamus and brainstem facilitate the expression of somatic anxiety symptoms, such as increased heart rate and sweating (Emmett et al., 2019). The amygdala's role is not just in threat perception but also in setting the preconditions for emotional experience by enhancing attention and perceptual encoding of salient events, thereby increasing their subjective impact (Anderson, 2007).

**The Prefrontal Cortex (PFC):** The prefrontal cortex, particularly the medial and orbitofrontal regions, exerts top-down regulatory control over limbic structures like the amygdala (Arnsten & Shanafelt, 2021). This "executive control" function is crucial for appraising threats realistically, inhibiting inappropriate fear responses, and regulating emotional states (Arnsten & Shanafelt, 2021). In GAD, a key diagnostic criterion is the "difficulty to control the worry" (Munir & Takov, 2021). This suggests a failure of top-down regulation. It is hypothesized that individuals with GAD have diminished PFC activity or impaired functional connectivity between the PFC and the amygdala (Arnsten & Shanafelt, 2021). Uncontrollable stress, a defining feature of GAD, is known to impair PFC function, potentially creating a vicious cycle where worry leads to stress, which further weakens the brain's ability to control worry (Arnsten & Shanafelt, 2021; Sandi, 2013).

**The Hippocampus:** The hippocampus, another critical limbic structure, is involved in memory consolidation and contextual fear conditioning (Meyer & Hamel, 2014). It helps the brain distinguish between safe and dangerous contexts. The hippocampus is also highly sensitive to the effects of chronic stress and elevated cortisol levels, which can impair its function and even reduce its volume over time (Pervanidou & Chrousos, 2018; Meyer & Hamel, 2014). Hippocampal dysfunction may contribute to the cognitive symptoms of GAD, such as difficulty concentrating and memory problems (Munir & Takov, 2021), as the brain struggles to allocate cognitive resources while being in a state of constant alert (Kennedy, 2008).

**The Anterior Cingulate Cortex (ACC):** The ACC is implicated in a wide range of functions, including error detection, conflict monitoring, and the integration of cognitive and emotional information (Matisz & Gruber, 2020). It is a key node in the network that connects the PFC with the amygdala. Dysfunction in the ACC is thought to contribute to the cognitive biases seen in anxiety, such as the tendency to focus on threatening information and ruminate on negative outcomes (Matisz & Gruber, 2020).

### Neuroimaging Findings

Direct neuroimaging evidence for GAD is not present in the provided sources. However, based on the functional roles of the brain regions discussed above and findings from studies of related conditions like depression and PTSD, a neurocircuitry model of GAD can be inferred. Functional magnetic resonance imaging (fMRI) studies in other anxiety disorders consistently show amygdala hyperactivity in response to emotional stimuli (Anderson, 2007). It is highly plausible that a similar pattern exists in GAD, reflecting the state of chronic threat detection.

Furthermore, studies of depression, which shares significant clinical and biological overlap with GAD, have revealed altered resting-state functional connectivity, particularly within the default mode network and fronto-limbic circuits (Chen & Gong, 2021). This suggests that the brains of individuals with mood and anxiety disorders are "wired" differently, with altered communication between key regulatory and emotional centers. It is hypothesized that in GAD, there is weakened connectivity between the PFC and the amygdala, representing a failure of the PFC to effectively dampen amygdala-driven anxiety signals (Arnsten & Shanafelt, 2021). This model aligns perfectly with the core clinical feature of GAD: worry that is both excessive (amygdala hyperactivity) and uncontrollable (PFC hypoactivity/dysregulation). Future research utilizing neuroimaging techniques will be essential to confirm these hypothesized structural and functional abnormalities specifically within the GAD population, which could provide objective biomarkers for the disorder and targets for novel interventions (Spence, 2006).

## Developmental Neurobiology

Generalized Anxiety Disorder, while often diagnosed in adulthood, does not emerge from a vacuum. Its origins are frequently rooted in developmental processes that begin early in life and unfold across the lifespan. The interaction of an individual's innate temperament, early life experiences, and the maturation of neural circuits creates a trajectory of either resilience or vulnerability to anxiety. The chronic, fluctuating course of GAD suggests a deeply embedded neurobiological pattern that is established over time.

### Onset, Course, and Critical Periods

Anxiety is a normal part of development, with different fears and worries characterizing different life stages (Bagnell, 2011). However, an anxiety disorder is diagnosed when these responses become extreme, persistent, and cause significant impairment (Kowalchuk et al., 2022). While GAD is noted to have a later onset than many other anxiety disorders such as specific phobias or separation anxiety (Szkodny et al., 2014), its precursors are often evident much earlier. The disorder can certainly have its onset in childhood or adolescence (Bagnell, 2011; Masi et al., 2002).

Early life represents a critical period for the "programming" of the body's stress response systems (Pervanidou & Chrousos, 2018). Exposure to significant or chronic stress during fetal life, infancy, or childhood—such as maternal stress during pregnancy, abuse, neglect, or family dysfunction—can lead to lasting changes in the HPA axis and autonomic nervous system (Pervanidou & Chrousos, 2018; van der Kolk, 1998; Bouras & Lazaratou, 2012). These early adverse experiences can sensitize the developing brain, creating a hyperreactive stress response that persists into adulthood and confers a heightened vulnerability to developing anxiety and depressive disorders (Pervanidou & Chrousos, 2018; Martins-Monteverde et al., 2017). Thus, what may manifest as GAD in a 30-year-old could have its neurobiological roots in traumatic events experienced decades earlier (van der Kolk, 1998).

Innate temperament is another crucial developmental factor. Some children exhibit a temperament style known as "behavioral inhibition," characterized by shyness, caution, and avoidance in new or unfamiliar situations (Bagnell, 2011). This temperament is considered a significant risk factor for the later development of anxiety disorders, including GAD and social phobia (Bagnell, 2011; Morris, 2004). This suggests a constitutional, possibly genetic, predisposition toward a more sensitive threat-detection system.

Once established, GAD typically follows a chronic and fluctuating course, with periods of remission and relapse often tied to life stressors (Szkodny et al., 2014; Mandos et al., 2009). The probability of recovery is low, and the likelihood of recurrence is high (Szkodny et al., 2014). This chronicity suggests that the underlying neurobiological dysregulations are not transient but represent a stable, maladaptive state. This state may involve neuroplastic changes in the brain, where circuits for worry and threat-appraisal become strengthened and entrenched over time, making the pattern of anxious responding habitual and difficult to control (Stahl, 2002). Adolescence is another key developmental window, a period of significant brain reorganization, particularly in the prefrontal cortex, which is responsible for executive function and emotional regulation (Sharma et al., 2014). The onset of GAD during this time may interfere with the normal development of these regulatory circuits, contributing to the persistence of the disorder into adulthood (Bagnell, 2011).

## Treatment Mechanisms

The effectiveness of various therapeutic interventions for GAD provides valuable insights into the disorder's underlying biology. Both pharmacotherapy and psychotherapy are thought to work by modulating the dysregulated neural circuits and neurochemical systems implicated in the disorder. The ultimate goal of treatment is not merely symptom reduction but the induction of lasting neuroplastic changes that promote resilience and restore normal emotional regulation.

### Biological Basis of Pharmacotherapy

The primary pharmacological agents used to treat GAD target the neurotransmitter systems believed to be central to its pathophysiology (Allgulander & Baldwin, 2013).

**Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs):** As first-line treatments, SSRIs and SNRIs directly implicate the serotonin and norepinephrine systems (Gautam et al., 2017; Allgulander & Baldwin, 2013). By blocking the reuptake of these neurotransmitters, they increase their concentration in the synaptic cleft, enhancing neurotransmission (Rosenbaum & Zajecka, 1997). The therapeutic effect of these drugs is not immediate, often taking several weeks to manifest (Rosenbaum & Zajecka, 1997; Kennedy, 2008). This delay suggests that their mechanism is more complex than simple neurotransmitter replenishment. The prolonged increase in synaptic serotonin and norepinephrine is thought to trigger a cascade of downstream neuroadaptive changes, including alterations in receptor sensitivity and gene expression, which ultimately lead to a "rewiring" or normalization of dysfunctional fear and worry circuits (Stahl, 2002). This process of neuroplasticity may involve strengthening top-down control from the prefrontal cortex and dampening the hyperactivity of the amygdala (Arnsten & Shanafelt, 2021).

**Benzodiazepines:** These agents provide rapid anxiolytic effects by potentiating the inhibitory action of GABA at the GABA-A receptor (Valente, 1996). Their mechanism highlights the role of insufficient GABAergic inhibition in the anxious state. By enhancing this "braking" system, benzodiazepines can quickly reduce the acute somatic and psychological symptoms of anxiety (Gautam et al., 2017). However, their potential for dependence and the development of tolerance suggests that the brain adapts to their presence, which can lead to a difficult withdrawal syndrome upon discontinuation (Bismuth et al., 1980). This underscores their utility for acute or short-term management rather than as a long-term solution for a chronic condition like GAD (Rangaraj & Pélissolo, 2006).

**Pregabalin:** While its precise mechanism in anxiety is not detailed in the provided literature, pregabalin is recommended as a first-line agent for GAD (Allgulander & Baldwin, 2013). Its known function as a modulator of voltage-gated calcium channels, which reduces the release of excitatory neurotransmitters like glutamate, suggests that it may work by dampening excessive neuronal excitability in key anxiety circuits.

### Biological Implications of Psychotherapy

While psychotherapy is a psychological intervention, its effectiveness is ultimately mediated by changes in the brain. Cognitive Behavioral Therapy (CBT), a first-line treatment for GAD, has demonstrated efficacy in correcting cognitive distortions and modifying maladaptive behaviors (Kavan et al., 2009; Gautam et al., 2017).

From a neurobiological perspective, CBT can be viewed as a form of "top-down" regulation. Techniques like cognitive restructuring help patients identify and challenge anxious thoughts, a process that likely engages and strengthens the regulatory functions of the prefrontal cortex (PFC) (Arnsten & Shanafelt, 2021). By learning to reappraise threats more realistically, patients may enhance the PFC's ability to inhibit the hyperactive amygdala response that drives the fear reaction (Anderson, 2007). Behavioral techniques, such as exposure, help to extinguish conditioned fear responses. This process of extinction learning is thought to involve the creation of new, non-anxious memories in the hippocampus and PFC that compete with and inhibit the original fear memory (Yadin & Foa, 2007). The durability of CBT's effects suggests that it induces lasting neuroplastic changes, effectively retraining the brain's anxiety circuits to respond more adaptively (Kavan et al., 2009). The combination of pharmacotherapy and psychotherapy may be particularly effective because it targets the dysregulated neurobiology from both "bottom-up" (neurochemical) and "top-down" (cognitive) directions (Gautam et al., 2017).

## Biological Subtypes and Heterogeneity

Generalized Anxiety Disorder, as defined by current diagnostic criteria, is a clinically heterogeneous condition (Munir & Takov, 2021). Patients can present with a wide variety of symptom combinations and severities; for some, cognitive worry and psychic anxiety are predominant, while for others, somatic symptoms like muscle tension and fatigue are the primary complaints (Szkodny et al., 2014; Gautam et al., 2017). This clinical variability strongly suggests the existence of underlying biological heterogeneity. It is unlikely that a single neurobiological model can account for all presentations of GAD. Instead, the disorder may represent a final common pathway for several distinct pathophysiological processes (Bamalan et al., 2023).

One potential source of heterogeneity lies in the relative contribution of different neurobiological systems. For example, some individuals with GAD might have a primary dysregulation of the serotonergic or noradrenergic systems, making them particularly responsive to SSRIs or SNRIs (Allgulander & Baldwin, 2013). In contrast, others may have a primary hypofunction of the GABAergic system, or a hyperreactive HPA axis, leading to different symptom profiles and potentially different treatment responses (van Praag, 1998; Vinkers et al., 2021). The varying prominence of somatic versus psychic anxiety could reflect differential involvement of brainstem autonomic centers versus cortico-limbic circuits (Tollefson et al., 1993; Kennedy, 2008).

The high rate of comorbidity with other psychiatric disorders, especially major depression, further points to potential subtypes (Pollack, 2001; Ninan, 2001). The "anxious depression" presentation, where symptoms of GAD and MDD are tightly interwoven, is extremely common in clinical practice (Tollefson et al., 1993; Vanin, 2008). This may represent a distinct neurobiological subtype with a shared genetic vulnerability and pathophysiology that differs from "pure" GAD or "pure" depression (Vinkers et al., 2021). These patients often have a more severe clinical course and may respond differently to treatment than those with either disorder alone (Hybels et al., 2006).

Symptom profiles may also delineate subtypes. For instance, the distinction between anxious apprehension (worry about future events) and anxious arousal (panic-like somatic symptoms) could be biologically meaningful (Gautam et al., 2017). Anxious apprehension may be more closely linked to dysfunction in prefrontal-striatal circuits involved in planning and anticipation, whereas anxious arousal may be tied more directly to brainstem and amygdala-driven autonomic hyperactivity (Emmett et al., 2019). The presence of specific symptom clusters, such as prominent sleep disturbance, could also point to specific biological mechanisms, such as disruptions in circadian rhythms or homeostatic sleep drive (Bonnet & Arand, 2013; Szkodny et al., 2014).

Identifying these potential biological subtypes is a crucial goal for future research. It holds the promise of moving beyond a "one-size-fits-all" approach to treatment. The development of biomarkers—whether genetic, neuroendocrine, inflammatory, or neuroimaging-based—could help to stratify patients into more homogeneous groups (Sun et al., 2016). This would allow for a more personalized medicine approach, where treatments are targeted to the specific underlying pathophysiology of an individual patient, potentially leading to more effective interventions and a higher likelihood of achieving remission (Mandos et al., 2009).

## Future Directions

While our understanding of the biological basis of GAD has advanced considerably, it is clear that many questions remain. The current model is built largely upon inferences from clinical symptomatology and the mechanisms of effective treatments, highlighting a need for more direct investigation into the disorder's core pathophysiology. Future research must leverage advances in neuroscience and genetics to move from a descriptive to a mechanistic understanding of GAD.

A primary goal should be the identification of reliable and specific biomarkers for the disorder (Sun et al., 2016). The clinical diagnosis of GAD relies on subjective symptom reports, which can overlap significantly with other conditions like depression and normal reactions to stress (Munir & Takov, 2021; Casey & Bailey, 2011). Objective biological markers derived from genetics, neuroendocrine profiles (e.g., cortisol rhythms), immune system activity (e.g., inflammatory cytokines), or neuroimaging could provide a more definitive basis for diagnosis, help to delineate subtypes, and predict treatment response (Vinkers et al., 2021; Sun et al., 2016).

Neuroimaging research is particularly crucial. While we can hypothesize about the roles of the amygdala, prefrontal cortex, and hippocampus based on studies of other disorders (Anderson, 2007; Arnsten & Shanafelt, 2021), dedicated structural and functional MRI studies in large, well-characterized GAD cohorts are needed. Such studies could clarify the precise nature of the circuit-level dysfunction, examining not just activity within regions but the functional connectivity between them during states of worry and at rest (Chen & Gong, 2021). This could validate the model of impaired prefrontal regulation of amygdala activity and provide a target for novel interventions, such as brain stimulation techniques (Spence, 2006).

Genetic research must move beyond establishing heritability to identifying specific risk genes and pathways (Ninan, 2001). Genome-wide association studies (GWAS) can pinpoint common genetic variants of small effect that contribute to GAD risk, while next-generation sequencing can identify rare variants with larger effects. Integrating these genetic findings with data on gene expression and protein function will be essential for understanding how genetic risk translates into altered neural function (Bamalan et al., 2023).

Furthermore, the development of novel therapeutic agents is a high priority (Hashimoto, 2010). While SSRIs and SNRIs are effective for many, a significant portion of patients do not achieve full remission (Mandos et al., 2009). Research into new targets beyond the monoamine systems is warranted. This could include agents that modulate the HPA axis (e.g., CRH antagonists), the glutamate system, or inflammatory pathways (Anisman et al., 2005).

Finally, a life-course perspective is essential. Longitudinal studies that follow individuals from childhood through adulthood are needed to understand how early risk factors, such as temperament and early life stress, interact with genetic vulnerability to shape brain development and lead to the onset of GAD (Bagnell, 2011; Pervanidou & Chrousos, 2018). Such research could identify critical windows for preventive interventions, potentially altering developmental trajectories and reducing the incidence of this chronic and disabling disorder.

## Conclusion

Generalized Anxiety Disorder is a complex and severe mental illness characterized by chronic, uncontrollable worry and a host of debilitating physical and psychological symptoms (Munir & Takov, 2021; Szkodny et al., 2014). The evidence reviewed in this chapter strongly indicates that GAD is not simply a psychological reaction to life's stressors, but a brain disorder rooted in distinct biological and neurological dysfunctions. The pathophysiology of GAD appears to involve a multifaceted interplay of genetic vulnerabilities and environmental factors, which together disrupt the homeostatic balance of key neurobiological systems (Bamalan et al., 2023; Ninan, 2001).

A cohesive, albeit still developing, model emerges from the available literature. At its core, GAD appears to be a disorder of hyperarousal and dysregulated threat processing. This is manifested through the overactivity of the sympathetic nervous system and the HPA axis, leading to the somatic symptoms of tension and fatigue (Chu et al., 2019; Vinkers et al., 2021; Gautam et al., 2017). This state of chronic stress is driven and maintained by dysfunction in central neural circuits, particularly a hyperactive amygdala that is inadequately regulated by the prefrontal cortex (Emmett et al., 2019; Arnsten & Shanafelt, 2021). This cortico-limbic imbalance is likely modulated by imbalances in key neurotransmitter systems, most notably serotonin, norepinephrine, and GABA, as evidenced by the efficacy of targeted pharmacotherapies (Allgulander & Baldwin, 2013).

The chronic and relapsing nature of GAD suggests that these functional alterations may be underpinned by long-term neuroplastic changes, potentially initiated by a combination of genetic predisposition and adverse developmental experiences (Szkodny et al., 2014; Pervanidou & Chrousos, 2018). The clinical heterogeneity of the disorder hints at underlying biological subtypes, which may differ in their primary site of dysfunction, be it neurochemical, neuroendocrine, or circuit-based.

While this biological framework provides a robust foundation for understanding GAD, it is crucial to acknowledge the significant gaps that remain. Much of our current knowledge is inferential, and dedicated research is required to delineate the specific genetic markers, molecular pathways, and neuroimaging signatures of the disorder. A deeper understanding of these mechanisms will be paramount for developing more effective, personalized treatments and, ultimately, preventive strategies. By integrating the biological, psychological, and social dimensions of GAD, we can move toward a more comprehensive model of care that addresses the whole person and offers greater hope for recovery from this pervasive and distressing condition.


## References

1. Abazari, N., Heydarinasab, L., Yaghubi, H., & Farahani, H. (2021). Efficacy of hypnotherapy on pain intensity and psychological distress among women with premenstrual dysphoric disorder, applicability of suggestions focused on cognitive flexibility and ego strength. Research Square (Research Square). https://doi.org/10.21203/rs.3.rs-835578/v1
2. Abbas, T. K. (2022). Separation Anxiety Disorder among Preschool Children in Baghdad / Iraq. Indian Journal of Public Health Research & Development. https://doi.org/10.37506/ijphrd.v13i2.17956
3. AbdulRahman, I., Yaqoob, Ú., & Bhatti, T. A. (2018). Sleep Disorders Caused by Depression. Clinical Depression. https://doi.org/10.4172/2572-0791.1000131
4. Agarwal, V., Sitholey, P., & Srivastava, C. (2019). Clinical practice guidelines for the management of dissociative disorders in children and adolescents. Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_493_18
5. Aghababaeian, H., & Ahvazi, L. A. (2018). Isn’t it Time to Use Opioid Drugs in Emergency Medical Services?. DOAJ (DOAJ: Directory of Open Access Journals).
6. Ahemad, M., Ahmad, P. M. F., & Shafaat, M. (2018). Effect of Dalak (Massage) in the Management of Sahar (Insomnia). https://doi.org/10.37591/rrjoush.v5i2.130
7. Ainsworth, P. (1998). Attention deficit hyperactivity disorder: diagnostic issues. Morecambe Bay medical journal. https://doi.org/10.48037/mbmj.v3i2.541
8. Ali, N., Rasheed, A., Tariq, I., Abdullah, F., Sarwar, A., Atta, R., & Qammer, Z. (2018). Adjunct Use of Low Dose Risperidone Verses Adjunct Use of Clonazepam with an SSRI in Treatment of Moderate to Severe Anxiety States; A Comparative Study. National Journal of Health Sciences. https://doi.org/10.21089/njhs.32.0051
9. Allgulander, C., & Baldwin, D. S. (2013). Pharmacotherapy of Generalized Anxiety Disorder. Modern trends in psychiatry. https://doi.org/10.1159/000351955
10. Altonbary, A. (2021). A Mental or Behavioural Post Traumatic Disorder.
11. Alvarenga, P. G. D., Hounie, A. G., Mercadante, M. T., Miguel, E. C., & Rosário, M. C. D. (2007). Obsessive-compulsive disorder: A historical overview.. https://doi.org/10.4324/9780203936870-7
12. Amores, F. B. C., Pérez, G. P. L., Torres, N. A. C., & Carpio, V. D. P. C. (2023). Sleep pattern impairment in nursing students according to NANDA. Medwave. https://doi.org/10.5867/medwave.2023.s1.uta111
13. Anderson, A. K. (2007). Feeling emotional: the amygdala links emotional perception and experience. Social Cognitive and Affective Neuroscience. https://doi.org/10.1093/scan/nsm022
14. Andrasik, F., Lipchik, G. L., McCrory, D. C., & Wittrock, D. A. (2005). Outcome Measurement in Behavioral Headache Research: Headache Parameters and Psychosocial Outcomes. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.2005.05094.x
15. Andrews, G., Creamer, M., Crino, R., Hunt, C., Lampe, L., & Page, A. C. (2002). General issues in anxiety disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781316134948.003
16. Anghelescu, A., Magdoiu, A. M., Chirilă, I., Verișezan, O., Opincariu, I., Mureșanu, D. F., & Blesneag, A. (2018). None. Romanian Journal of Neurology. https://doi.org/10.37897/rjn.2018.s
17. Anisman, H., & Merali, Z. (2003). Cytokines, stress and depressive illness: brain‐immune interactions. Annals of Medicine. https://doi.org/10.1080/07853890310004075
18. Anisman, H., Merali, Z., Poulter, M. O., & Hayley, S. (2005). Cytokines as a Precipitant of Depressive Illness: Animal and Human Studies. Current Pharmaceutical Design. https://doi.org/10.2174/1381612053381701
19. Antoniuk, S. A. (2013). [Non-epileptic disorders in infancy and adolescence].. PubMed.
20. Arnsten, A. F., & Shanafelt, T. D. (2021). Physician Distress and Burnout: The Neurobiological Perspective. Mayo Clinic Proceedings. https://doi.org/10.1016/j.mayocp.2020.12.027
21. Arredondo-Aldana, K., Mera-Posligua, M. J., & Alencastro, J. A. P. (2021). Trastorno Depresivo Persistente y Trastornos de Ansiedad Generalizada Proveniente de un Estrés Post Traumático Crónico: Presentación de un Caso Clínico. Revista Científica Arbitrada en Investigaciones de la Salud GESTAR. https://doi.org/10.46296/gt.v4i8edesp.0027
22. Arteaga, T. L., Amo, C., González, C. S., & Sánchez, D. H. (2013). Nonconvulsive status epilepticus and psychotic symptoms: case report.. PubMed. https://doi.org/10.1708/1292.14295
23. Arteaga, T. L., Amo, C., González, C. S., & Sánchez, D. H. (2016). Nonconvulsive status epilepticus and psychotic symptoms: case report Stato epilettico non convulsivo e sintomi psicotici: caso clinico.
24. Astafyev, V., & Labygina, A. (2018). Sleep features in menopausal women (literature review). Acta Biomedica Scientifica (East Siberian Biomedical Journal). https://doi.org/10.29413/abs.2018-3.3.11
25. Autor, S. (2002). CÁPSULAS PARA LA VIDA.- ANSIEDAD. Gaceta UNAM (2000-2009).
26. Ayoob, A., & Janakiram, C. (2021). Let's Focus on Frailty. Journal of Indian Association of Public Health Dentistry. https://doi.org/10.4103/jiaphd.jiaphd_93_21
27. Ba, V. D. K. (1998). [Psychology and psychobiology of childhood trauma].. PubMed.
28. Bagnell, A. (2011). Anxiety and Separation Disorders. Pediatrics in Review. https://doi.org/10.1542/pir.32.10.440
29. Baldwin, D. S., Ajel, K., & Garner, M. (2008). Anxiety disorders. Medicine. https://doi.org/10.1016/j.mpmed.2008.05.002
30. Baltacıoğlu, M., Eşsizoğlu, A., Yenilmez, Ç., & Kaptanoğlu, C. (2015). Differential diagnosis and psychodynamic approach in kleptomania: a case report. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. https://doi.org/10.5350/dajpn2015280107
31. Bamalan, O. A., Alosaimi, N. M., Alfryyan, A. A., Aljubran, H. J., Alanazi, F. H., & Siddiqui, Z. I. (2023). Generalized Anxiety Disorder: A Review of Current Literature in Saudi Arabia. Psychology. https://doi.org/10.4236/psych.2023.141003
32. Bando, H. (2021). Weather-Related Pain or Meteoropathy has been Attracting Attention. https://doi.org/10.36502/2021/hcr.6201
33. Baran, A. S. (2003). Sleep Disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511547256.028
34. Barch, D. M., Pagliaccio, D., Luking, K. R., Moran, E. K., & Culbreth, A. J. (2019). Pathways to Motivational Impairments in Psychopathology: Common Versus Unique Elements Across Domains. Nebraska Symposium on Motivation/The Nebraska symposium on motivation. https://doi.org/10.1007/978-3-030-27473-3_5
35. Barnes, T. R. E., & Paton, C. (2011). Do antidepressants improve negative symptoms in schizophrenia?. BMJ. https://doi.org/10.1136/bmj.d3371
36. Barnhill, J. W., Okuda, M., Simpson, H. B., Stein, D. J., Simpson, H. B., Phillips, K. A., Phillips, K. A., Mataix‐Cols, D., Cruz, L. F. D. L., & Stein, D. J. (2023). Obsessive-Compulsive and Related Disorders. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615375295.jb06
37. Barrio, J. A. E., & Argüello, A. V. (2003). Evaluación de psicoterapia de duelo en un centro de salud mental. https://doi.org/10.36576/summa.28399
38. Barton, S., Karner, C., Salih, F., Baldwin, D. S., & Edwards, S. J. (2014). Clinical effectiveness of interventions for treatment-resistant anxiety in older people: a systematic review. Health Technology Assessment. https://doi.org/10.3310/hta18500
39. Batta, A., & Farid, B. (2011). Addiction in Adolescents ---- A Current Trend.
40. Becker, S. P., & Barkley, R. A. (2018). Sluggish cognitive tempo. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198739258.003.0015
41. Beghi, E., Carpio, A., Forsgren, L., Hesdorffer, D. C., Malmgren, K., Sander, J. W., Tomson, T., & Hauser, W. A. (2009). Recommendation for a definition of acute symptomatic seizure. Epilepsia. https://doi.org/10.1111/j.1528-1167.2009.02285.x
42. Behrman, S., & Ebmeier, K. P. (2014). Can exercise prevent cognitive decline?. PubMed.
43. Bertelli, M. O., Groef, J. D., & Rondini, E. (2019). Phenomenological Psychopathology of Neurodiversity. https://doi.org/10.1093/oxfordhb/9780198803157.013.100
44. Bhatt, J. V. (2014). Stress physiology and impact of stress on coronary atherosclerotic heart diseases. Indian journal of applied basic medical sciences.
45. Bishop, M. D., & Hannibal, K. (2014). Chronic Stress, Cortisol Dysfunction, and Pain: A Psychoneuroendocrine Rationale for Stress Management in Pain Rehabilitation. Physical Therapy. https://doi.org/10.2522/ptj.20130597
46. Bismuth, C., Bellec, L., Dally, S., & Lagier, G. (1980). [Benzodiazepine physical dependence. 6 cases (author's transl)].. PubMed.
47. Bivoleanu, A., Avasiloaiei, A., Moscalu, M., & Stamatin, M. (2017). The Role of Follow-up in Monitoring the Outcomes of Prematurity in a Cohort of Romanian Infants. Balkan Medical Journal. https://doi.org/10.4274/balkanmedj.2015.1125
48. Blanc, F., & Verny, M. (2017). Prodromal stage of disease (dementia) with Lewy bodies, how to diagnose in practice?. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2017.0675
49. Blanco, C., & Bernardi, S. (2014). Gambling Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg62
50. Blumenthal, J. A., & Lett, H. S. (2005). Depression and Cardiac Risk. Journal of Cardiopulmonary Rehabilitation. https://doi.org/10.1097/00008483-200503000-00005
51. Boeft, M. D., Dessel, N. C.-V., & Wouden, J. C. V. D. (2017). How should we manage adults with persistent unexplained physical symptoms?. BMJ. https://doi.org/10.1136/bmj.j268
52. Bond, C., Morgenstern, J., & Milne, W. K. (2022). Hot off the press: <scp>MRI</scp> sensitivity for transient global amnesia. Academic Emergency Medicine. https://doi.org/10.1111/acem.14540
53. Bonevski, D., & Naumovska, A. (2018). Trauma and Anxiety Disorders throughout lifespan: Fear and anxiety from normality to disorder.. PubMed.
54. Bonnet, M. H., & Arand, D. L. (2013). Insomnia. https://doi.org/10.3920/9789086867639_003
55. Borchers, A., & Cagle, L. A. (2018). Look‐Alike Causes of Respiratory Distress. https://doi.org/10.1002/9781119028994.ch50
56. Bould, H., Lewis, G., Emond, A., & Crawley, E. (2010). Depression and anxiety in children with CFS/ME: cause or effect?. Archives of Disease in Childhood. https://doi.org/10.1136/adc.2009.173161
57. Bouras, G., & Lazaratou, E. (2012). [Emergence of early childhood trauma in adult psychiatric symptomatology].. PubMed.
58. Boyer, S. (2016). Contribution de l'analyse du signal vocal à la détection de l'état de somnolence et du niveau de charge mentale.
59. Boylan, K., & Eppel, A. (2008). The severe mood dysregulation phenotype: case description of a female adolescent.. PubMed.
60. Bran, C. (2021). BURNOUT VERSUS WELL-BEING IN ORGANIZATIONS. Journal Plus Education.
61. Bransfield, R. C., & Friedman, K. J. (2019). Differentiating Psychosomatic, Somatopsychic, Multisystem Illnesses and Medical Uncertainty. Healthcare. https://doi.org/10.3390/healthcare7040114
62. Brauer, A. A. (2021). Psychosocial Aspects of Sport Retirement Amongst Collegiate Student-Athletes in the United States. Routledge eBooks. https://doi.org/10.4324/9781003020189-4
63. Brinkmann, B. H. (2021). Mental Disorder Issues in People.
64. Bronstein, A. M., & Lempert, T. (2010). Management of the patient with chronic dizziness. Restorative Neurology and Neuroscience. https://doi.org/10.3233/rnn-2010-0530
65. Brooks, C. N., Talmage, J. B., & Mueller, K. L. (2012). Subjective, Objective, or Both?. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2012.marapr02
66. Brown, S. L. (2006). Deterioration. Epilepsia. https://doi.org/10.1111/j.1528-1167.2006.00682.x
67. Budiman, M. W. (2002). MODULASI RESPONS IMUN PADA MENCIT BALB/c YANG STRES AKIBAT STRESOR SUARA.
68. Budson, A. E., & O’Connor, M. K. (2021). How to manage emotional problems. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780190098124.003.0008
69. Buist‐Bouwman, M. A. (2007). Functional limitations associated with mental disorders : inescapable fact or avoidable reality?.
70. Burkart, J., Jong, M. C., Ilenkyo, L., Verwer, C., Weber, S., Keller, T., & Klement, P. (2017). P172 Results of a randomised controlled trial with a homeopathic complex medicinal product in children with sleep disorders and restlessness. https://doi.org/10.1136/archdischild-2017-313273.260
71. Burn, D. J. (2013). Approach to History Taking and Examination of the Movement Disorder Patient. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199609536.003.0002
72. Büki, B., & Tarnutzer, A. A. (2013). Central causes of vertigo, dizziness, and imbalance. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199680627.003.0009
73. Callahan, C. M., Austrom, M. G., & Unverzagt, F. W. (2004). Dementia and Late-Life Depression. https://doi.org/10.1093/oso/9780195149395.003.0021
74. Cano‐Vindel, A., Miguel-Tobal, J. J., González, H. M., & Díez, I. I. (1994). El afrontamiento de la ansiedad en las drogodependencias. Anales de Psicología.
75. Caplan, R., Bursch, B., & Leipzig, A. (2012). Somatization. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199843824.003.0079
76. Capurso, A., Capurso, C., Solfrizzi, V., Colacicco, A. M., D’Introno, A., & Panza, F. (2007). [Depression in old age: a diagnostic and therapeutic challenge].. Recenti Progressi in Medicina.
77. Carota, A., Diéguez, S., & Bogousslavsky, J. (2005). Psychopathology of stroke. Gériatrie et Psychologie Neuropsychiatrie du Viellissement.
78. Carvajal-Lohr, A., Flores‐Ramos, M., Montejo, S. I., & Vidal, C. G. (2016). Los trastornos de ansiedad durante la transición a la menopausia. Perinatología y Reproducción Humana. https://doi.org/10.1016/j.rprh.2016.03.003
79. Casanova, Y. C., Torres, M. N., Ramírez, M. D. L., Ferrer, A. B., Calvo, R. N., & Ramos, I. J. (2021). Plan de cuidados de enfermería para paciente con deterioro de la movilidad.. Revista Sanitaria de Investigación.
80. Casey, P. (2018). Making the diagnosis in clinical practice (DRAFT). Oxford University Press eBooks. https://doi.org/10.1093/med/9780198786214.003.0006
81. CASEY, P., & Bailey, S. (2011). Adjustment disorders: the state of the art. World Psychiatry. https://doi.org/10.1002/j.2051-5545.2011.tb00003.x
82. Castillo-Villanueva, E., Coy, P. E. C., Shejet, F. O., Durán, E. T., & Cabrera, D. M. (2010). Evaluación de funciones cognitivas: atención y memoria en pacientes con trastorno de pánico. Salud Mental.
83. Cha, Y., Baloh, R. W., Cho, C., Magnusson, M., Song, J., Strupp, M., Wuyts, F. L., & Staab, J. P. (2020). Mal de débarquement syndrome diagnostic criteria: Consensus document of the Classification Committee of the Bárány Society. Journal of Vestibular Research. https://doi.org/10.3233/ves-200714
84. Challacombe, F., & Wroe, A. L. (2013). A hidden problem: consequences of the misdiagnosis of perinatal obsessive–compulsive disorder. British Journal of General Practice. https://doi.org/10.3399/bjgp13x667376
85. Chaouloff, F., Dubreucq, S., Matias, I., & Marsicano, G. (2013). Physical activity feel-good effect:The role of endocannabinoids. Routledge eBooks. https://doi.org/10.4324/9780203132678-12
86. Chen, L. (2021). Pain Intensity is associated with Self-Reported Disability and Adolescents with Musculoskeletal Pain.
87. Chen, Z., & Gong, Q. (2021). Resting-State Functional Connectivity in Unipolar Depression. Cambridge University Press eBooks. https://doi.org/10.1017/9781108623018.007
88. Chiliza, B., & Vythilingum, B. (2011). Consultation liaison psychiatry in Africa – essential service or unaffordable luxury?. African Journal of Psychiatry. https://doi.org/10.4314/ajpsy.v14i4.1
89. Choo, K.-Q., Wl, L., How, C., & Ng, B. (2015). Hoarding in Singapore. Singapore Medical Journal. https://doi.org/10.11622/smedj.2015131
90. Chouinard, G., & Chouinard, V. (2015). New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000371865
91. Chu, B., Marwaha, K., Sanvictores, T., & Ayers, D. (2019). Physiology, Stress Reaction. StatPearls.
92. Chuster, A. (2019). Long-lasting hypnagogic states of mind, sub-thalamic fears and caesura. Routledge eBooks. https://doi.org/10.4324/9780429444364-15
93. Cienfuegos, J. J., Arriaga, M. Á. A., García, J. J., & Fernández, A. C. S. (2021). Propuesta de establecimiento de hábitos y rutinas que contemplen ejercicio y manejo del estrés para evitar el desgaste laboral durante el home office. Ciencia Latina Revista Científica Multidisciplinar. https://doi.org/10.37811/cl_rcm.v5i3.583
94. Clark, D. A., & Purdon, C. (2003). Cognitive theory and therapy of obsessions and compulsions. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139087094.006
95. Clark, J. D., Rager, D. R., & Calpin, J. P. (1997). Animal well-being. II. Stress and distress.. PubMed.
96. Clark, J. D., Rager, D. R., & Calpin, J. P. (1997). Animal well-being. III. An overview of assessment.. PubMed.
97. Cleeland, C. S., & Mendoza, T. R. (2010). Symptom measurement by patient report. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511780868.028
98. Coccolini, F., Improta, M., Picetti, E., Vergano, L. B., Catena, F., Angelis, N. D., Bertolucci, A., Kirkpatrick, A. W., Sartelli, M., Fugazzola, P., Tartaglia, D., & Chiarugi, M. (2020). Timing of surgical intervention for compartment syndrome in different body region: systematic review of the literature. World Journal of Emergency Surgery. https://doi.org/10.1186/s13017-020-00339-8
99. Cohen, R., Pereira, I., Garrido, M. M., Ferreira, B., & Sousa, M. D. C. (2023). Suicidal ideation in older people, a public health matter. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2023.1786
100. Compton, M. T., & Broussard, B. (2010). Psychosocial Treatments for Early Psychosis. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195372496.003.0016
101. Cooper, L., Copeland, S., Dailey, S., Downey, D., Petersen, M. C., Stimson, C., & Dyke, D. C. V. (2008). Feeding and swallowing dysfunction in genetic syndromes. Developmental Disabilities Research Reviews. https://doi.org/10.1002/ddrr.19
102. Copeland‐Linder, N., Onigu-Otite, E., Serico, J. M., Jamora, M., & Belcher, H. M. E. (2017). Neurobiology of Child Maltreatment and Psychological Trauma. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199937837.003.0181
103. Corona, G., Mannucci, E., Petrone, L., Fisher, A. D., Balercia, G., Scisciolo, G. D., Pizzocaro, A., Giommi, R., Chiarini, V., Forti, G., & Maggi, M. (2006). Psychobiological Correlates of Delayed Ejaculation in Male Patients With Sexual Dysfunctions. Andrology. https://doi.org/10.2164/jandrol.05154
104. Coronado, L. M. Q., Florez, D. A. C., & Tarazona, M. C. L. (2017). Prevalencia depresión en estudiantes universitarios Bucaramanga 2017.
105. Costa, G. (2012). [Stress of driving: general overview].. PubMed.
106. Costa, G., Accattoli, M. P., Garbarino, S., Magnavita, N., & Roscelli, F. (2013). [Sleep disorders and work: guidelines for health surveillance, risk management and prevention].. PubMed.
107. Cruz, B., Limeres, P. C., Campo, A. C. D., & Soler, A. F. (2021). Depression and hypothyroidism: Literature review and case report. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.884
108. Cruz, M. C. D., Camargo, R. P. D., Cruz, L. C. D., Schiefelbein, N., Cruz, D. M. D., & Cruz, M. C. C. D. (2020). Migrânea: revisão de literatura. ARCHIVES OF HEALTH INVESTIGATION. https://doi.org/10.21270/archi.v10i2.4670
109. Cupelli, R. H., Weise, A., Barbero, M., & Kool, J. (2017). Interim report: Development and evaluation of a three-week inpatient fatigue management education protocol for persons with MS-related fatigue.
110. Czajkowska‐Malinowska, M., & Cofta, S. (2014). Obturacyjny bezdech senny i jego społeczne następstwa.
111. Dahan, A., Velzen, M. V., & Niesters, M. (2014). Comorbidities and the Complexities of Chronic Pain. Anesthesiology. https://doi.org/10.1097/aln.0000000000000402
112. Dahlem, M. A., Mair, T., & Müller, S. C. (2004). Spatio-Temporal Aspects of a Dynamical Disease: Waves of Spreading Depression. Birkhäuser Basel eBooks. https://doi.org/10.1007/978-3-0348-7895-1_42
113. Dahm, K. T., Holte, H. H., Dalsbø, T. K., Straumann, G. H., & Reinar, L. M. (2017). Effect of Physical Activity without Use of Antipsychotics Compared to Physical Activity and Antipsychotics for Patients with Active Psychosis: A Systematic Review [Internet].
114. Daley, D. C., & Douaihy, A. (2019). Substance-Related Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926632.003.0002
115. Dange, V., & Biswas, D. (2021). A Brief Review on Postpartum Depression. Journal of Pharmaceutical Research International. https://doi.org/10.9734/jpri/2021/v33i60b34924
116. Datta, K. (2022). Does the Patient Have Pain, Headaches, High Blood Pressure, Diabetes, Stroke, Ventilation or Cardiac Disorders, or Other Problems?. CRC Press eBooks. https://doi.org/10.1201/9781003093381-12
117. Davis, S., Gupta, N., Samudra, M., & Javadekar, A. (2021). A case of frontal lobe syndrome. Industrial Psychiatry Journal. https://doi.org/10.4103/0972-6748.328859
118. Deakin, J., & Lennox, B. (2013). Psychotic symptoms in young people warrant urgent referral.. PubMed.
119. Dedeli, Ö., & Akyol, A. D. (2005). Yoğun Bakım Sendromu. Yoğun Bakım Hemşireliği Dergisi.
120. Delcea, C. (2019). Sexual deviances. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2019.12.119
121. Dennis, M., Warlow, C. P., Gijn, J. V., Wardlaw, J. M., Bamford, J., Hankey, G. J., Sandercock, P., Rinkel, G. J., Langhorne, P., Sudlow, C., & Rothwell, P. M. (2008). What are This Patient's Problems?: A Problem‐Based Approach to the General Management of Stroke. Stroke. https://doi.org/10.1002/9780470696361.ch11
122. Dias, I. M., Maia, I. D., Mello, L. M. R. D., Leite, I. C. G., & Leite, F. P. P. (2014). Evaluation of correlation among sleep bruxism and depression levels, chronic pain and nonspecific physical symptoms according to axis II of the Research Diagnostic Criteria/Temporomandibular disorders. RSBO Revista Sul-Brasileira de Odontologia.
123. DM, F. P. G. M., BSc, M. P. C. B., Boyd, D. M., & BSc, M. D. S. S. (2014). Major Medical Problems. https://doi.org/10.1002/9781118690345.ch8
124. Domínguez, M. R., Burgos, L. M., & Bergink, V. (2020). Perinatal Mood and Anxiety Disorders. Obstetrics and gynecology.. https://doi.org/10.1002/9781119450047.ch16
125. Domźał, T., Załeska, B., Kwasucki, J., & Gierczak-Walichnowska, J. (1980). [Diurnal rhythm of pain in sciatica. Preliminary report].. PubMed.
126. Donghi, A. (2005). ALCANCE DE LA APLICACIÓN DEL MODELO DE REDUCCIÓN DE DAÑOS AL CAMPO ASISTENCIAL EN EL TRATAMIENTO DE LAS ADICCIONES. XII Jornadas de Investigación y Primer Encuentro de Investigadores en Psicología del Mercosur.
127. Douglas, M. E., Kim, B., Mayer, G., Crosby, B., & Towe-Goodm, N. (2012). Maternal Depression, Mothering and Child Development. InTech eBooks. https://doi.org/10.5772/38048
128. Doyle, A., & Pollack, M. H. (2003). Establishment of Remission Criteria for Anxiety Disorders. The Primary Care Companion To The Journal of Clinical Psychiatry.
129. Doyle, A., & Pollack, M. H. (2003). Establishment of remission criteria for anxiety disorders.. PubMed.
130. Dragoș, D., Ionescu, O.-P., Micuţ, R., Ojog, D. G., & Tănăsescu, M. D. (2012). Psychoemotional features of a doubtful disorder: functional dyspepsia.. PubMed.
131. Dreyer-Oren, S. E., Mitnaul, L., & Holtzheimer, P. E. (2018). Mood Disorders. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615372423.sy25
132. Du, Y. (2013). Should antidepressants be used to treat childhood depression?. PubMed. https://doi.org/10.3969/j.issn.1002-0829.2013.01.001
133. Dugue, M., & Neugroschl, J. (2002). Anxiety disorders. Helping patients regain stability and calm.. PubMed.
134. Durán, L. V. B., González, M., & Álvarez, G. B. (2020). Trastorno por estrés postrauma. Revista Medica Sinergia. https://doi.org/10.31434/rms.v5i9.568
135. Dégeilh, F., Viard, A., Dayan, J., Guenolé, F., Egler, P., Baleyte, J., Eustache, F., & Guillery‐Girard, B. (2013). Memory impairment in post-traumatic stress disorder: Behavioral and neuroimaging findings. Revue de neuropsychologie.
136. Dılbaz, N., & Enez, A. (2013). Treatment of Generalized Anxiety Disorders: Unmet Needs. InTech eBooks. https://doi.org/10.5772/53453
137. D’cruz, M., Andrade, C., & Rao, T. S. (2020). The Expression of Intimacy and Sexuality in Persons With Dementia. Journal of Psychosexual Health. https://doi.org/10.1177/2631831820972859
138. Efthimiou, K., & Mitsi, C. (2015). [Infertility: psychological-psychopathological consequences and cognitive-behavioural interventions].. PubMed.
139. El-Hamady, M. M., El-Sayed, H., Bakry, S. E., & Youniss, M. (2020). Prevalence of Anxiety Disorders in Substance Related Disorders. Benha Journal of Applied Sciences. https://doi.org/10.21608/bjas.2020.137193
140. Elbert, T., Schauer, M., & Neuner, F. (2004). Memory of Traumatic Stress. Klinische Neurophysiologie. https://doi.org/10.1055/s-2004-831963
141. Emmett, S. R., Hill, N. A., & Dajas‐Bailador, F. (2019). Psychiatry. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199694938.003.0018
142. Enache, R. G. (2012). The relationship between anxiety, depression and self-esteem in women with breast cancer after surgery. Procedia - Social and Behavioral Sciences. https://doi.org/10.1016/j.sbspro.2012.01.096
143. Escribano, S. A. (2018). Estudio de la eficacia de un tratamiento psicológico breve en la disminución de la sensibilidad a la ansiedad en pacientes con trastorno de pánico.
144. Espinel, Z., & Shaw, J. A. (2018). PTSD in Children. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190259440.003.0012
145. Esquiliano, G. R., Ramírez, I. M., Valdés, A. T., & Aguilar, C. A. T. (2004). Daño neurológico secundario a hipoxia isquemia perinatal. Archivos de neurociencias (México, D.F.).
146. Evers, M. M., & Marin, D. B. (2002). Mood disorders. Effective management of major depressive disorder in the geriatric patient.. PubMed.
147. Faiz, A., & Ali, F. (2018). Concept of insomnia (Sahr) and its basic principles of management in unani system of medicine: A review. Deleted Journal.
148. Falloon, K., Arroll, B., & Fernando, A. (2008). Sleep disorder (insomnia). BMJ. https://doi.org/10.1136/bmj.a1245
149. Feder, H. M., & Wormser, G. P. (2021). Studying College Students for the Development of Infectious Mononucleosis and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciab075
150. Ferini‐Strambi, L., Sforza, M., Poletti, M., Giarrusso, F., & Galbiati, A. (2017). Daytime sleepiness: more than just Obstructive Sleep Apnea (OSA). La Medicina del lavoro. https://doi.org/10.23749/mdl.v108i4.6497
151. Fernando, A., Consedine, N. S., & Hill, A. (2014). Mindfulness for surgeons. ANZ Journal of Surgery. https://doi.org/10.1111/ans.12695
152. Fernández, A. A., Martín, Á. P., Martínez, M. I., Bustillo, M. A., Hernández, F. B., Labrado, J. D. L. C., Peñas, R. D.-D., Rivas, E. G., Delgado, C. P., Redondo, J. R., & Giménez, J. R. R. (2009). Chronic fatigue syndrome: aetiology, diagnosis and treatment. BMC Psychiatry. https://doi.org/10.1186/1471-244x-9-s1-s1
153. Fernández-Egea, E., & Jones, P. B. (2023). Schizophrenia. Cambridge University Press eBooks. https://doi.org/10.1017/9781911623137.065
154. Filipenka, H. (2021). Major depressive disorder..
155. Fine, L., Dubrovsky, B., & Spielman, A. J. (2011). Insomnia. BENTHAM SCIENCE PUBLISHERS eBooks. https://doi.org/10.2174/978160805153311101010137
156. Finsterer, J., & Zarrouk‐Mahjoub, S. (2013). Fatigue in Healthy and Diseased Individuals. American Journal of Hospice and Palliative Medicine®. https://doi.org/10.1177/1049909113494748
157. Fischer, T., Agar, M., Hosie, A., & Teodorczuk, A. (2020). Unpacking agitation in practice: a call for greater precision. Age and Ageing. https://doi.org/10.1093/ageing/afaa110
158. Flaer, P. J., & AlRubaie, M. (2017). Cannabidiol (CBD): An Innovative Pharmacological Treatment For Obsessive-Compulsive Disorder (OCD).
159. Fonseca, R. S. D., Nazaré, G. O. D., Silva, P. S. L. D., Fortes, G. N., & Lemos, A. L. (2017). SINTOMAS DEPRESSIVOS EM ACADÊMICOS DE UMA UNIVERSIDADE PÚBLICA NO OESTE DO ESTADO DO PARÁ, RELATO DE EXPERIÊNCIA. 13º Congresso Internacional Rede Unida.
160. Fowler, A. W. (2003). Patients need comfort and control in beds and chairs. BMJ. https://doi.org/10.1136/bmj.327.7427.1349-b
161. Franz, M. R., & Schepank, H. (1997). [Mood disorders. Prevalence and course of unspecified functional disorders from the epidemiologic and psychosomatic viewpoint].. PubMed.
162. Frazer, E. (2019). Post Traumatic Stress Disorder in Emergency Medical Services. CRC Press eBooks. https://doi.org/10.1201/9781315607450-20
163. Fricchione, G. L., Esch, T., Joos, S., & Teut, M. (2013). Self-Care, Stress Management, and Primary Care: From Salutogenesis and Health Promotion to Mind-Body Medicine. Evidence-based Complementary and Alternative Medicine. https://doi.org/10.1155/2013/327415
164. Frisbee, J. C., Brooks, S., Stanley, S., & d’Audiffret, A. C. (2015). An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents. Journal of Visualized Experiments. https://doi.org/10.3791/53109
165. Frisbee, J. C., Brooks, S., Stanley, S., & d’Audiffret, A. C. (2015). An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents. Journal of Visualized Experiments. https://doi.org/10.3791/53109-v
166. Galvez-Sánchez, C. M., Coba, P. D. L., Duschek, S., & Paso, G. A. R. D. (2020). Fibromyalgia Symptoms Overview. https://doi.org/10.32545/encyclopedia202009.0002.v2
167. Garay, M. A., Richards, S., Mj, M. U., & Luguercho, C. (2007). [Psychotic major depressive episode: target symptoms in males and females].. PubMed.
168. Gardiner, P. K., Rees, P. D., Adisesh, P. A., Zalk, P. D., Harrington, P., Gervais, D. R., & Saary, P. J. (2022). Psychosocial Aspects of the Workplace. https://doi.org/10.1002/9781119887638.ch11
169. Gautam, S., Jain, A., Gautam, M., Vahia, V., & Gautam, A. (2017). Clinical Practice Guidelines for the Management of Generalised Anxiety Disorder (GAD) and Panic Disorder (PD). Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.196975
170. Gentile, J. P. (2018). Aggression in Intellectual Disability. International Journal of Autism & Related Disabilities. https://doi.org/10.29011/2642-3227.000010
171. Gerc, K., & Makiełło-Jarzowa, G. (1998). [Psychological consequences of neurologic motor impairment from a developmental perspective].. PubMed.
172. Giannuzzi, R., Testa, A. C., Sollazzo, F., Petrongolo, L., Bernardini, L., & Daini, S. (2013). Psychiatric emergencies (part I): psychiatric disorders causing organic symptoms.. PubMed.
173. Giasuddin, N. A., & Hossain, M. J. (2020). Understanding Obsessive Compulsive Disorder and Management Options. Faridpur Medical College Journal. https://doi.org/10.3329/fmcj.v15i1.49009
174. Gillen, M., Rose, E., & Schwarze, J. (2014). Conduct Disorder. https://doi.org/10.63134/nbfb7032
175. Gillig, P. M., & Sanders, R. D. (2011). Higher cortical functions: attention and vigilance.. PubMed.
176. Ginting, D. A., Jayady, A., Habibi, M. M., Andarmoyo, S., & Irawan, A. (2020). Mental health problems in covid-19 situation. European Journal of Molecular & Clinical Medicine.
177. Glucksman, M. L., & Kramer, M. (2017). Manifest Dream Content as a Predictor of Suicidality. Psychodynamic Psychiatry. https://doi.org/10.1521/pdps.2017.45.2.175
178. Goldberg, S., & Chapman, J. (2014). Practice question. Nursing Older People. https://doi.org/10.7748/nop.26.10.14.s18
179. Goldstein, T. R. (2010). Bipolar Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0134
180. Gooblar, J., & Beaudreau, S. A. (2018). Anxiety Disorders in Late Life. Oxford Research Encyclopedia of Psychology. https://doi.org/10.1093/acrefore/9780190236557.013.415
181. Gordon, M. F., & Leder, A. (2012). Serotonin Syndrome. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-835-5_18
182. Gordon, M. L., Doghramji, P. P., & Lieberman, J. A. (2007). Stay Awake! Understanding, Diagnosing, and Successfully Managing Narcolepsy. Current psychiatry.
183. Grabowska–Grzyb, A. (2005). Zaburzenia psychiczne w padaczce. Polski Przegląd Neurologiczny.
184. Grieger, T. A. (2005). PTSD plus depression are comorbid conditions but depression can occur independently in the acute aftermath of trauma. Evidence-Based Mental Health. https://doi.org/10.1136/ebmh.8.1.27
185. Grigorenko, E. L., Klin, A., & Volkmar, F. R. (2003). Annotation: Hyperlexia: disability or superability?. Journal of Child Psychology and Psychiatry. https://doi.org/10.1111/1469-7610.00193
186. Grimmer, K., Larsen, T. M., & Kumar, S. (2004). Effectiveness of manipulation and mobilisation for headaches: an evidence-based systematic review. JBI Library of Systematic Reviews. https://doi.org/10.11124/jbisrir-2004-665
187. Grossman, M. N. (2021). Several weeks of low mood, decreased appetite, and poor sleep after changing schools. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197577479.003.0007
188. Guerdjikova, A. I., McElroy, S. L., Barger, S. D., Barth, J., Farrelly, S., & Brohan, E. (2019). Recent Advances in Depressive Disorder.
189. Gupta, K., & Mamidi, P. (2018). Yaksha grahonmada: Bipolar disorder with obsessive-compulsive disorder?. International Journal of Yoga - Philosophy Psychology and Parapsychology. https://doi.org/10.4103/ijny.ijoyppp_35_17
190. Gupta, K., & Mamidi, P. (2022). Madonmada of Bhela samhita. Journal of Applied Consciousness Studies. https://doi.org/10.4103/ijoyppp.ijoyppp_16_21
191. Gupta, M. A. (2013). Review of somatic symptoms in post-traumatic stress disorder. International Review of Psychiatry. https://doi.org/10.3109/09540261.2012.736367
192. Guskiewicz, K. M., & Goldman, S. B. (2013). A Changing Landscape: Traumatic Brain Injury in Military Combat and Civilian Athletics. The FASEB Journal. https://doi.org/10.1096/fj.13-1101ufm
193. Guthrie, M., Zubatsky, M., & Smith, C. W. (2015). Family Stress and Counseling. Family Medicine. https://doi.org/10.1007/978-1-4939-0779-3_30-1
194. Gutiérrez-Achury, A. M., Vanegas-Vidal, M., Salazar-Díaz, L. I., & Arías, G. M. A. (2009). Factores farmacológicos y no farmacológicos que afectan la adherencia al tratamiento de los pacientes esquizofrénicos dados de alta en la Unidad de Salud Mental del Hospital Universitario de Neiva entre enero y junio del 2008. RFS Revista Facultad de Salud. https://doi.org/10.25054/rfs.v1i2.43
195. Gómez‐Revuelta, M., Blanco, L. S., Ruíz, M. J., Jenaro, G. P. D. S., Rodríguez, R. L., Olivares, O. P., & Morales, N. N. (2017). A Clinical review about differential diagnosis and comorbidities on premenstrual dysphoric disorder. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.577
196. Hakan, M., & Kemal, A. R. (2009). Sporcularda Durumluk ve Sürekli Kaygi Düzeylerinin Bazi Değişkenlere Göre İncelenmesi Examxination Of The Level Of State - Trial Anxiety Of Sportsmen According To Some Variables.
197. Halaby, A., Haddad, R., & Naja, W. (2013). Non-Antidepressant Treatment of Social Anxiety Disorder: A Review. Current Clinical Pharmacology. https://doi.org/10.2174/15748847113089990059
198. Halligan, S. L. (2014). Neurobiological outcomes in the offspring of postnatally depressed mothers: Causes and consequences. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199676859.003.0019
199. Halm, M. A. (2018). Night Shift Naps Improve Patient and Workforce Safety. American Journal of Critical Care. https://doi.org/10.4037/ajcc2018861
200. Hammett, E., Fernandez-Carbonell, C., Crayne, C. B., Boneparth, A., Cron, R. Q., & Radhakrishna, S. M. (2020). Adolescent Sjogren’s syndrome presenting as psychosis: a case series. Pediatric Rheumatology. https://doi.org/10.1186/s12969-020-0412-8
201. Hartanto, H., Hartono, B., & Nathawira, K. M. (2022). Sikap Berdiri Lama Dalam Menimbulkan Nyeri Punggung Bawah. Jurnal MedScientiae. https://doi.org/10.36452/jmedscientiae.v1i2.2661
202. Hartung, P. J., & Penn, M. A. (2004). Work Stress and Health. https://doi.org/10.1093/oso/9780195149395.003.0041
203. Hashimoto, K. (2010). Editorial:[Novel Therapeutic Drugs for Neuropsychiatric Disorders]. The Open Medicinal Chemistry Journal. https://doi.org/10.2174/1874104501004020001
204. Hatcher-Kay, C., & King, C. A. (2003). Depression and Suicide. Pediatrics in Review. https://doi.org/10.1542/pir.24-11-363
205. Hawkes, M. A., & Hocker, S. E. (2021). Status Epilepticus. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197512166.003.0057
206. Heilbroner, P. L., & Castaneda, G. Y. (2007). Pediatric neurology : essentials for general practice. Lippincott Williams & Wilkins eBooks.
207. Henriksson, J., & Sundberg, C. J. (2015). [Being in motion reduces the risk of disease and premature death].. PubMed.
208. Hernández, M., ESQUIVEL, N., & López, M. (2014). Fisiopatología, diagnóstico diferencial y tratamiento de la apnea emotiva grave: A propósito de un caso clínico. Revista chilena de pediatría. https://doi.org/10.4067/s0370-41062014000400012
209. Hildawati, H. (2021). PROBLEMATIKA GANGGUAN KECEMASAN PADA LANJUT USIA DI LINGKUNGAN SOSIAL. Moderasi Jurnal Studi Ilmu Pengetahuan Sosial. https://doi.org/10.24239/moderasi.vol2.iss2.41
210. Hillman, D. R., Carlucci, M., Charchaflieh, J., Cloward, T. V., Gali, B., Gay, P. C., Lyons, M. M., McNeill, M. M., Singh, M., Yılmaz, M., & Auckley, D. (2023). Society of Anesthesia and Sleep Medicine Position Paper on Patient Sleep During Hospitalization. Anesthesia & Analgesia. https://doi.org/10.1213/ane.0000000000006395
211. Hirano, S., Ichikawa, Y., Sato, B., Takefuji, Y., & Satoh, F. (2023). Successful treatment of myalgic encephalomyelitis/chronic fatigue syndrome using hydrogen gas: four case reports. Medical Gas Research. https://doi.org/10.4103/2045-9912.385441
212. Hirschfeld, R. M. A., Calabrese, J. R., Frye, M. A., Lavori, P. W., Sachs, G., Thase, M. E., & Wagner, K. D. (2007). Defining the clinical course of bipolar disorder: response, remission, relapse, recurrence, and roughening.. PubMed.
213. Hosang, G. M., Korszun, A., Jones, L., Jones, I., McGuffin, P., & Farmer, A. (2012). Life-event specificity: bipolar disorder compared with unipolar depression. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.bp.112.111047
214. Hossmann, K. (1998). Experimental models for the investigation of brain ischemia. Cardiovascular Research. https://doi.org/10.1016/s0008-6363(98)00075-3
215. Housley, S. B., Patel, D., Nyabuto, E., & Reynolds, R. M. (2021). Spinal cord detethering without laminectomy or laminotomy. Surgical Neurology International. https://doi.org/10.25259/sni_942_2021
216. Hvolby, A., Jørgensen, J., & Bilenberg, N. (2005). [Sleeping disorders can imitate attention deficit/hyperactivity disorder].. PubMed.
217. Hybels, C. F., Blazer, D. G., & Steffens, D. C. (2006). Partial remission. A common outcome in older adults treated for major depression.. PubMed.
218. Ignatova, E. S., Bogaevskaya, O. U., & Yumashev, A. V. (2021). Psychodiagnostics as a mandatory element of patient protocols in dentistry. Journal of International Society of Preventive and Community Dentistry. https://doi.org/10.4103/jispcd.jispcd_60_21
219. Ingrassia, G. F. (2012). HISTORICAL EVOLUTION OF MEDICAL KNOWLEDGE IN THE FIELD OF VEGETATIVE STATE.
220. Iorga, M., Stârcea, I. M., Munteanu, M., & Sztankovszky, L.-Z. (2014). PSYCHOLOGICAL AND SOCIAL PROBLEMS OF CHILDREN WITH CHRONIC KIDNEY DISEASE.
221. Irgebaeva, N., & Akmusaeva, M. (2020). ANXIETY OF THE PERSONEMOTIONAL STATUS. BULLETIN Series Psychology. https://doi.org/10.51889/2020-3.1728-7847.04
222. Is, B., Golovoda, A., Pneumaticos, S. G., & Vlamis, J. (2021). The effect of depression in hospitalization and rehabilitation of patients with spinal cord injury. Acta Orthopaedica Et Traumatologica Hellenica.
223. Isenberg, K., & Garcia, K. S. (2008). Syndromes of Brain Dysfunction Presenting with Cognitive Impairment or Behavioral Disturbance: Delirium, Dementia, and Mental Disorders Caused by a General Medical Condition. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-252-6_2
224. Islam, M. T., Chowdhury, M. R., Snigdha, K. S. R., & Bhuiyan, M. S. I. (2014). Impact of Ankylosing Spondylitis on Paitents Work Status, Functional Disability and Quality of Life - A Review. BIRDEM Medical Journal. https://doi.org/10.3329/birdem.v4i2.33196
225. İbiloğlu, A. O., Atlı, A., Kaya, M. C., Baran, A. S., & Sır, A. (2016). Psychogenic Gait Disorder After a Stressful Life Event: Case Report. Turkiye Klinikleri Journal of Case Reports. https://doi.org/10.5336/caserep.2015-46732
226. Jak, H. J. O. A. J., ColÃ, A. M. G. C. C., Drummond, D. M. S. S. P., & Twamley, J. B. L. E. W. (2015). Sleep Disturbance, Psychiatric, and Cognitive Functioning in Veterans with Mild to Moderate Traumatic Brain Injury. Journal of Sleep Disorders Treatment & Care. https://doi.org/10.4172/2325-9639.1000153
227. Jenkins, J. M., & Oatley, K. (1998). The Development of Emotion Schemas in Children: Processes That Underlie Psychopathology. https://doi.org/10.1093/oso/9780195093216.003.0003
228. Jevtovic, J., Jovanović, J., Grujicic, M. V. –., & Vujcic, J. (2021). OCCUPATIONAL STRESS IN COMPUTER OPERATORS. Knowledge International Journal.
229. Johnston, M. P., & Coward, D. D. (2001). Cancer-Related Fatigue: Nursing Assessment and Management. AJN American Journal of Nursing. https://doi.org/10.1097/00000446-200104001-00005
230. Júnior, E. L. D. S., & González, L. F. C. (2021). A DEPRESSÃO COMO FATOR DE RISCO PARA O CÂNCER. https://doi.org/10.51161/rems/1558
231. Kanner, A. M., & Dunn, D. W. (2004). Diagnosis and Management of Depression and Psychosis in Children and Adolescents With Epilepsy. Journal of Child Neurology. https://doi.org/10.1177/088307380401900108
232. Kanner, A. M., & LaFrance, W. C. (2015). Epilepsy and Seizures. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199731855.003.0043
233. Kar, S. K. (2015). Psychiatric aspects of pediatric epilepsy: Focus on anxiety disorder. Medical Journal of Dr D Y Patil University. https://doi.org/10.4103/0975-2870.160777
234. Karakatsoulis, G. N., Tsapakis, E.-M., & Fountoulakis, K. Ν. (2021). Clinical characteristics and treatment of treatment-resistant bipolar depression. Psychiatriki. https://doi.org/10.22365/jpsych.2021.048
235. Karila, L., Lowenstein, W., Coscas, S., Benyamina, A., & Reynaud, M. (2009). [Complications of cocaine addiction].. PubMed.
236. Kasatkin, D. S. (2006). [Possible mechanisms of chronic fatigue syndrome in multiple sclerosis].. PubMed.
237. Katzman, M. A. (2021). The Diagnosis of Major Depressive Disorder is based on the Person's Reported Experiences and a Mental Status Examination. Journal of Aging and Geriatric Medicine.
238. Kaur, R., Kaur, G., Patil, R., Gupta, R., & Patil, H. (2021). A REVIEW STUDY ON TYPES AND MANAGEMENT OF ANXIETY. Journal of Emerging Technologies and Innovative Research.
239. Kavan, M., Elsasser, G. N., & Barone, E. J. (2009). Generalized anxiety disorder: practical assessment and management.. PubMed.
240. Kavan, M., Elsasser, G. N., & Barone, E. J. (2012). The physician's role in managing acute stress disorder.. PubMed.
241. Kennedy, J. E., Jaffee, M. S., & Cooper, D. (2013). Posttraumatic Stress Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625154.da08
242. Kennedy, S. H. (2008). Core symptoms of major depressive disorder: relevance to diagnosis and treatment. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2008.10.3/shkennedy
243. Khaikin, Y., & Mercimek‐Andrews, S. (2016). STXBP1 Encephalopathy with Epilepsy.
244. Khan, I., & Khan, M. A. (2021). Sensory and Perceptual Alterations. StatPearls.
245. Khune, A. A., Rathod, H., Deshmukh, S. P., & Chede, S. B. (2023). Mental health, depressive disorder and its management: A review. GSC Biological and Pharmaceutical Sciences. https://doi.org/10.30574/gscbps.2023.25.2.0464
246. Kiecolt‐Glaser, J. K., Derry, H. M., & Fagundes, C. P. (2015). Inflammation: Depression Fans the Flames and Feasts on the Heat. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2015.15020152
247. Kim, H. J., & Choi, Y. Y. (2021). Fatigue and Associated Factors among Airline Pilots. The Korean Journal of Aerospace and Environmental Medicine. https://doi.org/10.46246/kjasem.210009
248. King, A., Rawitt, R. R., Barboza, K. C., & Hollander, E. (2003). Cognitive and Neuropsychological Assessment of Children with Autism Spectrum Disorders. CRC Press eBooks. https://doi.org/10.3109/9780203911723-9
249. Kissane, D. W., & Yates, P. (2018). Psychological and Existential Distress. Routledge eBooks. https://doi.org/10.4324/9781315378473-16
250. Klipstein, A., & Nydegger, A. (2013). Rückenschmerzen im Erwerbstätigenalter. Therapeutische Umschau. https://doi.org/10.1024/0040-5930/a000440
251. Knapen, J., Vancampfort, D., Schoubs, B., Probst, M.-T., Sienaert, P., Haake, P., Peuskens, J., & Pieters, G. (2009). Exercise for the Treatment of Depression. The Open Complementary Medicine Journal. https://doi.org/10.2174/1876391x00901010078
252. Koo, B. B. (2011). Sleep-Related Movement Disorders. BENTHAM SCIENCE PUBLISHERS eBooks. https://doi.org/10.2174/978160805267711101010045
253. Koo, S. K. (2018). Depression Status in Korea. Osong Public Health and Research Perspectives. https://doi.org/10.24171/j.phrp.2018.9.4.01
254. Korff, M. V., & Simon, G. (1996). The Relationship Between Pain and Depression. The British Journal of Psychiatry. https://doi.org/10.1192/s0007125000298474
255. Kotade, K. B., Pandit, B. S., Gaware, V. M., Dolas, R. T., Dhamak, K. B., Somwanshi, S. B., Nikam, V. K., & Khadse, A. N. (2011). KNOWING DEPRESSION AND PHARMACOLOGICAL, NON-PHARMACOLOGICAL APPROACHES FOR ITS TREATMENT.
256. Kowalchuk, A., González, S., & Zoorob, R. (2022). Anxiety Disorders in Children and Adolescents.. PubMed.
257. Krahn, L. E., MD, & Jowsey‐Gregoire, S. G. (2006). Psychiatry. CRC Press eBooks. https://doi.org/10.1201/b21610-26
258. Krystal, A. D., Edinger, J. D., & Wohlgemuth, W. K. (2013). Sleep and Circadian Rhythm Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370016.mt08
259. Kumari, V. (2021). New insights on affective morbidity and childhood maltreatment. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.121
260. Lanzaro, M. (2017). A new syndrome? The sport identification addiction and the case of Italian football ultra-fanatical support. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.508
261. Lazare, A. (2021). Psychiatry. Routledge eBooks. https://doi.org/10.4324/9781003261599-25
262. Ledezma, C., Soto, K., & Suárez, M. I. (2015). Depresión en el adulto mayor en Costa Rica: un problema social. Revista Hispanoamericana de Ciencias de la Salud.
263. Lee, V. (2021). Mental Health Impacts during COVID-19. Journal of Anxiety & Depression. https://doi.org/10.46527/2582-3264.136
264. Leff, J., & Warner, R. (2006). Economic obstacles to employment. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511543937.011
265. Lemogne, C., Pitron, Jy, R., Limosin, F., & Cathébras, P. (2019). What attitude towards a patient with somatoform disorder?. PubMed.
266. Lewis, C. F. (2015). Anxiety disorders including post traumatic stress disorder (PTSD). Oxford University Press eBooks. https://doi.org/10.1093/med/9780199360574.003.0035
267. León, M. S. M. D. (2017). Trastorno por déficit de atención con hiperactividad: autorregulación emocional y funciones ejecutivas.
268. Lim, H., Kwon, Y.-J., Lee, J.-E., & Cho, S. (2013). Reconsideration of Psychasthenia- Two Cases. Journal of Oriental Neuropsychiatry. https://doi.org/10.7231/jon.2013.24.3.245
269. Linden, M. (2020). Euthymic suffering and wisdom psychology. World Psychiatry. https://doi.org/10.1002/wps.20718
270. Lockhart, P. J. (2001). Fetal alcohol spectrum disorders for mental health professionals - a brief review. Current Opinion in Psychiatry. https://doi.org/10.1097/00001504-200109000-00007
271. Loitman, J. E., & Deshields, T. L. (2010). Psychiatric Palliative Care Issues. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-590-3_4
272. Lu, M. (2009). The meaning of Mental Disorder in Chinese Medicine. Journal of Korean Medical classics.
273. Lucchesi, L. M., Pradella-Hallinan, M., Lucchesi, M., & Moraes, W. A. D. S. (2005). O sono em transtornos psiquiátricos. Brazilian Journal of Psychiatry. https://doi.org/10.1590/s1516-44462005000500006
274. Luijendijk, H. J. (2010). Vascular Heart and Brain Disease and Incident Late-Life Depression.
275. Luthra, M. (2017). Depression: Current Scenario with reference to India. Indian Journal of Community Health. https://doi.org/10.47203/ijch.2017.v29i01.001
276. Lyketsos, C. G. (2012). F1‐01‐02: Tackling overlap of neuropsychiatric symptoms in Alzheimer's and other dementias: Toward a unified approach to evaluation and treatment. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2012.05.191
277. L�pine, J.-P., & Briley, M. (2004). The epidemiology of pain in depression. Human Psychopharmacology Clinical and Experimental. https://doi.org/10.1002/hup.618
278. Macenski, C. L. (2021). Recurrent episodes of intense fear, shortness of breath, racing heart, and sweating. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197577479.003.0014
279. Macneil, C., Hasty, M., Conus, P., Berk, M., & Scott, J. (2009). Social rhythm regulation. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511757389.008
280. Macovei, A. L., Dobrin, I., Chiriță, V., Burlui, A., Dobrin, P.-R., & Rezuş, E. (2019). Chronic fatigue and psychiatric comorbidities in patients with rheumatic disorders. Bulletin of Integrative Psychiatry. https://doi.org/10.36219/bpi.2019.03.08
281. Madan, A., Frueh, B. C., Fowler, J. C., Stomberg, S., Bradshaw, M. R., Kelly, K. R., Weinstein, B., Luttrell, M., Danner, S. G., & Beidel, D. C. (2020). “Operator syndrome”: A unique constellation of medical and behavioral health-care needs of military special operation forces. The International Journal of Psychiatry in Medicine. https://doi.org/10.1177/0091217420906659
282. Madrid, P. A., Grant, R., Reilly, M. J., & Redlener, N. B. (2006). Challenges in Meeting Immediate Emotional Needs: Short-term Impact of a Major Disaster on Children's Mental Health: Building Resiliency in the Aftermath of Hurricane Katrina. PEDIATRICS. https://doi.org/10.1542/peds.2006-0099u
283. Maercker, A. (2013). 2984 – Disorders specifically associated with stress. European Psychiatry. https://doi.org/10.1016/s0924-9338(13)77503-5
284. Mahon, S. M., & Carr, E. (2021). Fatigue/Lack of Endurance: Common Side Effect. Clinical journal of oncology nursing. https://doi.org/10.1188/21.cjon.s2.25
285. Mamidi, P., & Gupta, K. (2018). Uraga grahonmada: Extrapyramidal movement disorder?/Tourette syndrome-plus?. Indian Journal of Health Sciences and Biomedical Research (KLEU). https://doi.org/10.4103/kleuhsj.kleuhsj_10_18
286. Mandos, L. A., PharmD, Reinhold, J. A., Bcps, Bcpp, & Rickels, K. (2009). Achieving Remission in Generalized Anxiety Disorder.
287. Mann, B., & Wilson, H. (2013). Diagnosing somatisation in adults in the first consultation: moving beyond diagnosis by exclusion. British Journal of General Practice. https://doi.org/10.3399/bjgp13x674602
288. Maramis, M. M. (2009). Mengenal Gangguan Mood pada Perempuan.
289. Martens, W. H. J., & Kahn, W. A. (2003). Emotional Capacities and Sensitivity in Psychopaths.
290. Martins-Monteverde, C. M. S., Padovan, T., & Juruena, M. F. (2017). Trauma and stressor-related disorders. Medicina (Ribeirão Preto). https://doi.org/10.11606/issn.2176-7262.v50isupl1.p37-50
291. Martínez‐Salio, A., Soler-Algarra, S., Calvo-Garcia, I., & Sánchez-Martín, M. (2007). Síndrome de ingesta nocturna relacionada con el sueño con respuesta al topiramato. Revista de Neurología. https://doi.org/10.33588/rn.4505.2007188
292. María, A., Sancho, R., & Pita, B. L. (2005). Trastornos de ansiedad en la infancia y en la adolescencia.
293. Masi, G., Millepiedi, S., & Mucci, M. (2002). Efficacy of newer antidepressants for childhood anxiety disorders. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.2.4.523
294. Matheson, J. K. (2008). Sleep disorders in the elderly.. Medicine and health, Rhode Island.
295. Matisz, C. E., & Gruber, A. J. (2020). Neuroinflammatory Remodeling of the Anterior Cingulate Cortex as a Key Driver of Mood Disorders in Gastrointestinal Disease and Disorders. https://doi.org/10.20944/preprints202009.0593.v1
296. Mayou, R., & Sharpe, M. (1997). Treating medically unexplained physical symptoms. BMJ. https://doi.org/10.1136/bmj.315.7108.561
297. Mayo‐Wilson, E., Montgomery, P., & Dennis, J. A. (2007). PROTOCOL: Personal assistance for children and adolescents (0‐18) with both physical and intellectual impairments. Campbell Systematic Reviews. https://doi.org/10.1002/cl2.41
298. Mazzoni, P., Kimhy, D., Khan, S., Posner, K., Maayan, L., Eilenberg, M., Walsh‐Messinger, J., Kestenbaum, C. J., & Corcoran, C. M. (2009). Childhood Onset Diagnoses in a Case Series of Teens at Clinical High Risk for Psychosis. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2008.0105
299. McCann, M. E., & Kain, Z. N. (2001). The Management of Preoperative Anxiety in Children: An Update. Anesthesia & Analgesia. https://doi.org/10.1097/00000539-200107000-00022
300. McCrory, P., Meeuwisse, W., Echemendía, R. J., Iverson, G. L., Dvořák, J., & Kutcher, J. S. (2013). What is the lowest threshold to make a diagnosis of concussion?. British Journal of Sports Medicine. https://doi.org/10.1136/bjsports-2013-092247
301. McLeod, T. C. V., & Register‐Mihalik, J. K. (2011). Clinical Outcomes Assessment for the Management of Sport-Related Concussion. Journal of Sport Rehabilitation. https://doi.org/10.1123/jsr.20.1.46
302. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). [Clinical practice guideline. Diagnosis and treatment of insomnia in the elderly].. PubMed.
303. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). Diagnóstico y tratamiento del insomnio en el adulto mayor.
304. Melca, I. A., & Fortes, S. (2014). Obesidade e transtornos mentais: construindo um cuidado efetivo. Revista Hospital Universitário Pedro Ernesto. https://doi.org/10.12957/rhupe.2014.9794
305. Melehin, A. (2021). Cognitive-Behavioral Therapy in the Treatment of Recurrent Isolated Sleep Paralysis. Archives in Neurology & Neuroscience. https://doi.org/10.33552/ann.2021.11.000760
306. Melville-Drewes, A. (2018). Posttraumatische Verbitterungsstörung, Burn-out ... – arbeitsplatzbezogene psychische Störungen in der amtsärztlichen Begutachtung. Das Gesundheitswesen. https://doi.org/10.1055/s-0038-1639183
307. Mera-Posligua, M. J., Arredondo-Aldana, K., & Alencastro, J. A. P. (2021). Trastorno de ansiedad generalizada abordado desde la terapia de aceptación y compromiso: caso clínico. Revista Científica Arbitrada en Investigaciones de la Salud GESTAR. https://doi.org/10.46296/gt.v4i8edesp.0032
308. Mervis, C. Β., Morris, C. A., Klein-Tasman, B., Velleman, S. L., & Osborne, L. R. (2015). 7q11.23 Duplication Syndrome.
309. Mev, D., Nama, D., Agarwal, P., & Sharma, V. (2021). HOMOEOPATHIC APPROACH IN THE MANAGEMENT OF ANXIETY DISORDERS. International Journal of AYUSH.
310. Meyer, J. S., & Hamel, A. F. (2014). Models of Stress in Nonhuman Primates and Their Relevance for Human Psychopathology and Endocrine Dysfunction. ILAR Journal. https://doi.org/10.1093/ilar/ilu023
311. Michie, S. (2002). CAUSES AND MANAGEMENT OF STRESS AT WORK. Occupational and Environmental Medicine. https://doi.org/10.1136/oem.59.1.67
312. Mikkelsen, M. E., & Iwashyna, T. J. (2020). Persistent problems and recovery after critical illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0395
313. Mikkelsen, M. E., & Iwashyna, T. J. (2020). Persistent problems and recovery after critical illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0395_update_001
314. Miller, M. W., Marx, B. P., & Keane, T. M. (2010). Posttraumatic Stress Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0699
315. Mirzaa, G., Conway, R. L., Graham, J. M., & Dobyns, W. B. (2013). PIK3CA-Related Segmental Overgrowth.
316. Molla, L., Preza, K., & Simaku, A. (2021). Low Back Pain Diagnostic Approach. Medicus. https://doi.org/10.58944/bcsf1353
317. Montalto, S. A. (2021). Intrapartum Asphyxia and Its Sequelae. Cambridge University Press eBooks. https://doi.org/10.1017/9781108863049.061
318. Monti, J. M., & Pandi‐Perumal, S. R. (2014). Role of zolpidem in the management of primary and comorbid insomnia. https://doi.org/10.2217/fmeb2013.13.146
319. Montoya, A., & Alejandra, M. (2020). Estrés laboral y sus consecuencias en la salud que afectan el rendimiento.
320. Moore, D. P., & Puri, B. K. (2012). Textbook of Clinical Neuropsychiatry and Behavioral Neuroscience 3E.
321. Morris, T. L. (2004). Diagnosis of Social Anxiety Disorder in Children. CRC Press eBooks. https://doi.org/10.3109/9780203026106-12
322. Moscovich, M., Estupinan, D., Qureshi, M. Y., & Okun, M. S. (2013). Shell shock: Psychogenic gait and other movement disorders—A film review. Tremor and Other Hyperkinetic Movements. https://doi.org/10.5334/tohm.132
323. Mott, T., McConnon, M. L., & Rieger, B. (2012). Subacute to chronic mild traumatic brain injury.. PubMed.
324. Moura, G. S., Neves, L. M. T., Giorelli, A. S., Florido, P., & Gomes, M. D. M. (2013). Transtornos do sono: visão geral Sleep disorders: overview.
325. Mulak, A. (2003). Testing of visceral sensitivity.. Journal of Physiology and Pharmacology.
326. Mumdzhiev, H., & Slancheva, B. (2013). [Intrauterine hypotrophy and programming the health status. Late problems in newborns with intrauterine hypotrophy].. PubMed.
327. Munir, S., & Takov, V. (2021). Generalized Anxiety Disorder. StatPearls.
328. Munir, S., Takov, V., & Coletti, V. A. (2021). Generalized Anxiety Disorder (Nursing).
329. Murakami, M., & Matsuno, T. (2010). Musculoskeletal Chronic Pain and Psychosocial Stress. Journal of Nihon University Medical Association. https://doi.org/10.4264/numa.69.183
330. Mut, E. A., Pălădoiu, C., & Stănescu, M. (2021). Somatoform and conversion disorders as psychological defences. Journal of Educational Sciences & Psychology. https://doi.org/10.51865/jesp.2021.1.19
331. Nadeem, M. S., Murtaza, B. N., Al-Ghamdi, M. A., Ali, A., Zamzami, M. A., Khan, J. A., Ahmad, A., Rehman, M. U., & Kazmi, I. (2021). Autism - A Comprehensive Array of Prominent Signs and Symptoms. Current Pharmaceutical Design. https://doi.org/10.2174/1381612827666210120095829
332. Nader, K., & Williams, M. B. (2018). Trauma- and Stressor-Related Disorders. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780190634841.013.22
333. Naeim, M. (2021). How to control stress caused by COVID-19?. Healthy Aging Research.
334. Nakayama, H., Mihara, S., Sakuma, H., Kitamura, D., & Higuchi, S. (2014). SY08-3 * CO-MORBIDITY OF INTERNET ADDICTION. Alcohol and Alcoholism. https://doi.org/10.1093/alcalc/agu052.39
335. Narang, T., Garima, & Singh, S. M. (2016). Psychosexual disorders and dermatologists. Indian Dermatology Online Journal. https://doi.org/10.4103/2229-5178.182349
336. Nater, U. M., Miller, A. H., Reeves, W. C., & Raison, C. L. (2010). Chronic Fatigue Syndrome. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0176
337. NB, U., GI, A., Ya, N., Si, I., NA, J., & FF, A. (2018). The level of anxiety in women with graves’ disease. Endocrinology&Metabolism International Journal. https://doi.org/10.15406/emij.2018.06.00227
338. Neto, L. C. D. S., Miranda, G. A., Cunha, L. L. G. D., Canto, B. E. S., Strufaldi, V. P., Tetti, M. F., Akerman, M., & Matos, L. L. D. (2013). Consequências individuais e socioeconômicas da síndrome da apneia obstrutiva do sono. ABCS Health Sciences. https://doi.org/10.7322/abcshs.v38i1.6
339. Nicholson, K., & Martelli, M. F. (2004). The Problem of Pain. Journal of Head Trauma Rehabilitation. https://doi.org/10.1097/00001199-200401000-00002
340. Nielen, M. M. A. (2003). Where emotion meets cognition: studies on executive function in obsessive-compulsive disorder.
341. Ninan, P. T. (2001). Recent perspectives on the diagnosis and treatment of generalized anxiety disorder.. PubMed.
342. Noeker, M. (2004). [Factitious disorder and factitious disorder by proxy].. PubMed.
343. Ocon, A. J. (2013). Caught in the thickness of brain fog: exploring the cognitive symptoms of Chronic Fatigue Syndrome. Frontiers in Physiology. https://doi.org/10.3389/fphys.2013.00063
344. Ojha, A., & Kumar, D. (2021). Psychological Factors in Fibromyalgia and Chronic Fatigue Syndrome: Implications in Counseling. https://doi.org/10.56173/bjcp.2021.1102
345. Ojimba, C., Isidahome, E. E., Odenigbo, N., Umudi, O. D., & Olayinka, O. (2019). Catatonia in major depressive disorder: diagnostic dilemma. A case report. Journal of Psychology & Clinical Psychiatry. https://doi.org/10.15406/jpcpy.2019.10.00651
346. Oliveira, S., Canha, J., & Pereira, S. P. (2013). 2362 – Is it a prodrome of psychosis? Or is it naanxious disorder? A case report. European Psychiatry. https://doi.org/10.1016/s0924-9338(13)77202-x
347. Olmos-López, A., Ibarra-Aguilar, J., Cornelio-Nieto, J. O., Ocaña-Hernández, L. A., Márquez-Amaya, M. A., Luna-López, N. A., Reséndiz-Aparicio, J. C., & Rodríguez‐Leyva, I. (2019). Clinical guideline: status epilepticus in children and adults. DELETED. https://doi.org/10.24875/rmn.m19000031
348. Os, J. V., Praag, H. M. V., & Kloet, E. R. D. (2004). Stress, the brain and depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544422.010
349. Ownby, R. L. (2006). Medication adherence and cognition. Medical, personal and economic factors influence level of adherence in older adults.. PubMed.
350. PADMAWATI, N. N., Ardani, I. G. A. I., Ariyani, A., Ariani, P., & Purnamasidhi, ‪. A. W. (2021). Psychopharmaceutical Therapy and Supportive Psychotherapy for COVID-19 Patients with Depression. International Journal of Medical Reviews and Case Reports. https://doi.org/10.5455/ijmrcr.covid-19-psychopharmaceutical-therapy-172-1608192666
351. Paidi, G., Jean, M., Oduwole, A., Gautam, N., Kapoor, K., & Paidi, R. (2022). Chronic Unexplained Vomiting: A Case Report on Psychogenic Vomiting. Cureus. https://doi.org/10.7759/cureus.25959
352. Paradela, E. M. P. (2011). Depressão em idosos. Revista Hospital Universitário Pedro Ernesto (TÍTULO NÃO-CORRENTE). https://doi.org/10.12957/rhupe.2011.8850
353. Paredes, D. F. D., Farfán, J. C. P., Orellana, J. M. F., & Legarda, A. A. B. (2019). Trastorno disfórico premenstrual. RECIAMUC. https://doi.org/10.26820/reciamuc/3.(1).enero.2019.199-217
354. Park, J. S., Belfort, M. A., & Norwitz, E. R. (2001). Pathogenesis and treatment of eclampsia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511545634.030
355. Parmet, S., Burke, A. E., & Glass, R. M. (2006). Insomnia. JAMA. https://doi.org/10.1001/jama.295.24.2952
356. Patel, A. I., Yadav, A., Patel, A. B., & Vyas, A. J. (2023). Post Covid-19 Women Complications. Asian Journal of Nursing Education and Research. https://doi.org/10.52711/2349-2996.2023.00017
357. Pavlova, M. (2017). Sleep and its disorders in women. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199682003.003.0051
358. Pereira, S. M. P., Guimarães, S. K. G., Marques, A., & Borges, S. (2008). Electroconvulsivotherapy in the elderly, indications, risks and side-effects. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2008.01.611
359. Perkinson, R. R., & Jongsma, A. E. (1997). The Chemical Dependence Treatment Planner.
360. Perrin, R., Edwards, J., & Hartley, P. (1998). An evaluation of the effectiveness of osteopathic treatment on symptoms associated with Myalgic Encephalomyelitis. A preliminary report. Journal of Medical Engineering & Technology. https://doi.org/10.3109/03091909809009993
361. Pervanidou, P., & Chrousos, G. P. (2011). Stress and obesity/metabolic syndrome in childhood and adolescence. International Journal of Pediatric Obesity. https://doi.org/10.3109/17477166.2011.615996
362. Pervanidou, P., & Chrousos, G. P. (2018). Early-Life Stress: From Neuroendocrine Mechanisms to Stress-Related Disorders. Hormone Research in Paediatrics. https://doi.org/10.1159/000488468
363. Petruševičienė, D., & Kriščiūnas, A. (2003). [Occupational therapy for patients after stroke].. PubMed.
364. Peña, M. A. M. (2013). Síndrome de sobreentrenamiento. IATREIA.
365. Phillips, M. R. (2009). Is distress a symptom of mental disorders, a marker of impairment, both or neither?. PubMed.
366. Pignalberi, C., Ricci, R. P., & Santini, M. (2002). [Psychological stress and sudden death].. PubMed.
367. Pollack, M. H. (2001). Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder.. PubMed.
368. Popa, T., & Delcea, C. (2019). Voyeurism and Scopophilia. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2019.12.11.121
369. Popkirov, S., Asadi‐Pooya, A. A., Duncan, R., Gigineishvili, D., Hingray, C., Kanner, A. M., LaFrance, W. C., Pretorius, C., & Reuber, M. (2019). The aetiology of psychogenic non‐epileptic seizures: risk factors and comorbidities. Epileptic Disorders. https://doi.org/10.1684/epd.2019.1107
370. Post, R. M. (2002). Introduction: Emotion and Psychopathology. https://doi.org/10.1093/oso/9780195126013.003.0048
371. Powers, S. W., Gilman, D. K., & Hershey, A. D. (2006). Headache and Psychological Functioning in Children and Adolescents. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.2006.00583.x
372. Praag, H. M. V. (1998). Anxiety and increased aggression as pacemakers of depression. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1998.tb05971.x
373. Prabu, M. I. J., & Sharma, C. P. (2021). STRESS AND HYPERTENSION. IDC International Journal. https://doi.org/10.47211/idcij.2021.v08i01.009
374. Priya, A., Chaturvedi, S., Bhasin, S., Bhatia, M., & Radhakrishnan, G. (2018). Depression, anxiety and stress among pregnant women: A community-based study. Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_230_17
375. Pysden, K. (2015). Alternating hemiplegia of childhood. Journal of Pediatric Neurology. https://doi.org/10.3233/jpn-2010-0337
376. Quintero, J. M. B., Castellanos, A., & Santos, L. S. D. L. (2018). Efectividad de una intervención pre-quirúrgica de enfermería; en ansiedad de pacientes sometidos a colecistectomía del Hospital General Regional No.1 Vicente Guerrero de Acapulco, 2017.
377. Qureshi, M. A., & Wasti, S. A. (2014). Lay-off Survivor Sickness Syndrome (Investigating the Lasting Impact on Performance of Survivors in the Context of Age and Gender in Private Sector Organizations of Pakistan). International Journal of Human Resource Studies. https://doi.org/10.5296/ijhrs.v4i3.6078
378. Rabiepoor, S., & yas, A. (2018). Awareness, Attitude and Performance of Men Regarding Premenstrual Syndrome. International Journal of Women s Health and Reproduction Sciences. https://doi.org/10.15296/ijwhr.2018.76
379. Radmanović, M. B., & Burgić, S.-S. (2020). Comorbidity in Children and Adolescents with ADHD. IntechOpen eBooks. https://doi.org/10.5772/intechopen.94527
380. Rahayu, S. U. B. (2016). PENCEGAHAN GANGGUAN KECEMASAN DENGAN INTERVENSI BERBASIS WEB. Jurnal Ilmiah Widya.
381. Rains, J., & Poceta, J. S. (2006). Headache and Sleep Disorders: Review and Clinical Implications for Headache Management. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.2006.00578.x
382. Rains, J., & Poceta, J. S. (2006). Sleep and Headache Disorders: Clinical Recommendations for Headache Management. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.2006.00567.x
383. Rajesh, M., & Kumar, C. P. G. (2014). Influence of interactional relationship on stress among women executives in software company in Chennai. EXCEL International Journal of Multidisciplinary Management Studies.
384. Rakofsky, J. J., & Dunlop, B. W. (2014). Treating Bipolar Mania in the Outpatient Setting: Enlist the Help of Family, Employ Evidence-Based Pharmacologic and Psychotherapeutic Strategies. Current psychiatry.
385. Rangaraj, J., & Pélissolo, A. (2006). [Anxiety disorders in the elderly: Clinical and therapeutic aspects].. PubMed.
386. Rani, M. K. S., Fathima, S. T., Gayathri, S. L., Pavani, M., & Swathi, Y. (2022). Detection of Autism Spectrum Disorder using Machine Learning. International Journal of Advanced Research in Science Communication and Technology. https://doi.org/10.48175/ijarsct-7600
387. Rapkin, A. J., & Mikacich, J. (2007). Clinical evaluation and management. CRC Press eBooks. https://doi.org/10.3109/9781435628168-19
388. RAPOPORT, J. L., & Fiske, A. P. (1998). The New Biology Of Obsessive-Compulsive Disorder: Implications for Evolutionary Psychology. Perspectives in biology and medicine. https://doi.org/10.1353/pbm.1998.0063
389. Reddy, M. S. (2014). Irritability as a Criterion in Diagnosis of Child and Adolescent Bipolar Disorder: Thorny Road Ahead. Indian Journal of Psychological Medicine. https://doi.org/10.4103/0253-7176.130954
390. Reddy, S., Elsayem, A., & Talukdar, R. (2005). Palliative Care. CRC Press eBooks. https://doi.org/10.1201/b14119-59
391. Reeven, N. V., & Cahyanti, I. Y. (2021). Gambaran Postpartum Depression pada Figur Ayah. Buletin Riset Psikologi dan Kesehatan Mental (BRPKM). https://doi.org/10.20473/brpkm.v1i1.27601
392. Reinares, M., Martínez‐Arán, A., & Vieta, E. (2019). Psychoeducation for Patients and Family Members. Cambridge University Press eBooks. https://doi.org/10.1017/9781108589802.004
393. Riaz, Y., & Sergi, C. (2021). Feeding Disability In Children.
394. Roberts, A. R., & Yeager, K. R. (2009). Indicators of a Crisis-Prone Person. https://doi.org/10.1093/oso/9780195382907.003.0004
395. Roberts, A. R., & Yeager, K. R. (2009). Stress Symptomatology and the General Adaptation Syndrome. https://doi.org/10.1093/oso/9780195382907.003.0008
396. Robinson, R. G. (2006). Mechanism and treatment of poststroke anxiety disorder. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544231.034
397. Rodríguez, M. G., Doval, A. I., & Fernández, C. O. (2009). El maltrato encubierto. Psicoloxía clínica: anuario.
398. Rogol, A. M. (2020). Ethical Issues in the Evaluation and Treatment of Depression. FOCUS The Journal of Lifelong Learning in Psychiatry. https://doi.org/10.1176/appi.focus.20200006
399. Ronad, S. V., Patail, C. S., Gondbal, S. H., TC, K., Ronad, M., Pankaja, T., Badesgol, R., & Singhal, P. K. J. (2019). Professionals in metro cities suffer from anxiety disorder. Nursing & Care Open Access Journal. https://doi.org/10.15406/ncoaj.2019.06.00198
400. Rosenbaum, J. F., & Zajecka, J. (1997). Clinical management of antidepressant discontinuation.. PubMed.
401. Routledge, F. S., Dunbar, S. B., Higgins, M., Rogers, A. E., Feeley, C. A., Ioachimescu, O. C., Euwer, K., Eapen, D. J., & Quyyumi, A. A. (2015). Insomnia Symptoms Are Associated With Abnormal Endothelial Function. The Journal of Cardiovascular Nursing. https://doi.org/10.1097/jcn.0000000000000295
402. Rowe, P. C., Underhill, R., Friedman, K. J., Gurwitt, A., Medow, M. S., Schwartz, M., Speight, N., Stewart, J. M., Vallings, R., & Rowe, K. S. (2017). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer. Frontiers in Pediatrics. https://doi.org/10.3389/fped.2017.00121
403. Rucci, J. M., & Feinstein, R. E. (2014). Neurocognitive Disorders and Mental Disorders Due to Another Medical Condition. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199326075.003.0005
404. Rüstemova, D., Genç, A., Bora, G., & Tur, B. S. (2017). A thermal dysregulation problem after breast cancer surgery; what could be?. Medicine. https://doi.org/10.1097/md.0000000000007027
405. Sahakian, B. J., & Morein‐Zamir, S. (2011). Depression and resilience: insights from cognitive, neuroimaging, and psychopharmacological studies. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780199600434.003.0023
406. Sakauye, K., & Nininger, J. E. (2018). Trauma in Late Life. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190457136.003.0009
407. Salcedo, A. K. M., Escobar, J. C. C., & Diaz, L. Y. V. (2019). Ansiedad dental en adultos en la clínica odontológica de la universidad cooperativa de colombia de pasto.
408. Saletu‐Zyhlarz, G., Anderer, P., & Saletu, B. (2013). [Sleep disorders in psychiatry and their treatment].. PubMed.
409. Sandi, C. (2013). Stress and cognition. Wiley Interdisciplinary Reviews Cognitive Science. https://doi.org/10.1002/wcs.1222
410. Santucci, K. T. T., Miranda, A. H., Oliveira, A. J. R., & Vieira, A. F. D. B. (2022). Psicologia organizacional e do trabalho e a humanização no contexto hospitalar. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.15
411. Sardesai, A., Muneshwar, K. N., Bhardwaj, M., & Goel, D. B. (2023). The Importance of Early Diagnosis of Somatic Symptom Disorder: A Case Report. Cureus. https://doi.org/10.7759/cureus.44554
412. Sari, M. N., Sulyaman, S., Sulistiono, A., & Ramadhian, M. R. (2016). Gangguan Kepribadian dan Perilaku Akibat Penyakit, Kerusakan, dan Disfungsi Otak pada Pria Usia 45 Tahun. Jurnal Medula.
413. Sarkar, S. (2016). Psychiatric Polypharmacy, Etiology and Potential Consequences. Current Psychopharmacologye. https://doi.org/10.2174/2211556005666160916124719
414. SARSU, M., & SARIGÖZ, O. (2020). Bireysel Sosyal Medya Kullanımının Psikolojik Semptomlar Üzerine Etkileri. İnsan ve Toplum Bilimleri Araştırmaları Dergisi. https://doi.org/10.15869/itobiad.786579
415. Sazonov, S. (2014). EPA-0651 – The complexity of psychopathological symptom as a possible indication of mental disease's etiology. European Psychiatry. https://doi.org/10.1016/s0924-9338(14)78023-x
416. Scherbaum, N., & Specka, M. (2014). Komorbide psychische Störungen bei Opiatabhängigen. Suchttherapie. https://doi.org/10.1055/s-0033-1363240
417. Schildkrout, B. (2011). Specific Mental Signs and Symptoms. https://doi.org/10.1002/9781118083598.ch9
418. Schildkrout, B. (2014). Delirium. https://doi.org/10.1002/9781394260447.ch2
419. Schildkrout, B. (2014). Disease #47: Parasomnias: Sleepwalking and Night Terrors. https://doi.org/10.1002/9781394260447.ch75
420. Schildkrout, B. (2014). Disease #53: Postconcussion Syndrome. https://doi.org/10.1002/9781394260447.ch81
421. Schildkrout, B. (2014). Disease #54: Premenstrual Dysphoric Disorder and Premenstrual Syndrome. https://doi.org/10.1002/9781394260447.ch82
422. Schildkrout, B. (2014). Disease #58: Restless Legs Syndrome. https://doi.org/10.1002/9781394260447.ch86
423. Schildkrout, B. (2014). Mood, Affect, and Emotion. https://doi.org/10.1002/9781394260447.ch4
424. Schildkrout, B. (2014). Vegetative Symptoms. https://doi.org/10.1002/9781394260447.ch23
425. Schorb, A., Niebauer, J., Aichhorn, W., Schiepek, G., Scherr, J., & Claussen, M. (2021). Overtraining from a sports psychiatry perspective. German Journal of Sports Medicine. https://doi.org/10.5960/dzsm.2021.496
426. Sejdić, E., Malandraki, G. A., & Coyle, J. L. (2018). Computational Deglutition: Using Signal- and Image-Processing Methods to Understand Swallowing and Associated Disorders [Life Sciences]. IEEE Signal Processing Magazine. https://doi.org/10.1109/msp.2018.2875863
427. Sengstock, B., & Curtis, J. (2023). Excited delirium syndrome. Journal of Paramedic Practice. https://doi.org/10.12968/jpar.2023.15.8.cpd1
428. Setyawan, M. K., Maliawan, S., Mahadewa, T. G. B., Niryana, I. W., & Wardhana, D. P. W. (2021). Gangguan pola bangun-tidur setelah cedera kepala. Intisari Sains Medis. https://doi.org/10.15562/ism.v12i2.1013
429. Shakhar, K., & Fleisig, D. (2013). How to Cope with Stress and Depression in Women with Recurrent Miscarriage. https://doi.org/10.1002/9781118749012.ch13
430. Sharif, A. T. (2018). Effect of Stress on Academic Performance of Undergraduate Medical Students.
431. Sharma, S., Kishore, J., & Gupta, V. (2014). Adolescent Mental Health: From Normalcy to Illness. Indian Journal of Youth and Adolescent Health.
432. Sharma, V. (2021). Peripartum anxiety: parsing heterogeneity in clinical settings. Brazilian Journal of Psychiatry. https://doi.org/10.1590/1516-4446-2021-1952
433. Sharp, L. K., & Lipsky, M. S. (2002). Screening for depression across the lifespan: a review of measures for use in primary care settings.. PubMed.
434. Sharpe, M., & Wilks, D. (2002). ABC of psychological medicine: Fatigue. BMJ. https://doi.org/10.1136/bmj.325.7362.480
435. Shirley, E. A., Hudspeth, L. J., & Maynard, J. R. (2018). Managing Sports-related Concussions From Time of Injury Through Return to Play. Journal of the American Academy of Orthopaedic Surgeons. https://doi.org/10.5435/jaaos-d-16-00684
436. Silva, H. M. D., & Cardoso, L. V. (2021). RISADA PEGA: A Mnemonic Method in Portuguese for Alarm Criteria in Emergency Headaches. Deleted Journal. https://doi.org/10.48208/headachemed.2021.supplement.29
437. Silverman, M. N., & Deuster, P. A. (2014). Biological mechanisms underlying the role of physical fitness in health and resilience. Interface Focus. https://doi.org/10.1098/rsfs.2014.0040
438. Singh, G., & Kaur, P. (2017). ANTIPSCYHOTIC INDIAN HERBAL FORMULATIONS: AN OVERVIEW. Indian Research Journal of Pharmacy and Science. https://doi.org/10.21276/irjps.2017.4.1.6
439. Singh, N., & Koul, S. (2016). Anxiety Related To Chronic Cervical Spodylosis: A Case Report. International Journal of Indian Psychology. https://doi.org/10.25215/0303.116
440. Singh, P. K. (2015). Psychogenic Headache in School Going Children. Indian Journal of Health and Wellbeing.
441. Sinha, S., Moss, A. J., & Calkins, H. (2007). The etiology of sudden death. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544828.014
442. Skraban, C., Grand, K., & Deardorff, M. A. (2019). WDR26-Related Intellectual Disability.
443. Slavić, A., & Manenica, I. (2005). Comparison in Heart Rate Variability during Working and Non-working Nights.
444. Spence, S. A. (2006). All in the mind? The neural correlates of unexplained physical symptoms. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.12.5.349
445. Sreshta, N., Pope, H. G., Hudson, J. I., & Kanayama, G. (2017). Muscle Dysmorphia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190254131.003.0007
446. Sriramoju, M., Keerthi, V. P., Alumdri, D. B., & Akula, S. (2014). Evaluation of antidepressant activity of ethanolic and aqueous extract of Solanum tuberosum peel. Journal of Comprehensive Pharmacy. https://doi.org/10.37483/jcp.2014.1503
447. Stahl, S. M. (2002). Can Psychopharmacologic Treatments That Relieve Symptoms Also Prevent Disease Progression?. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v63n1101
448. Steffens, D. C., Blazer, D. G., & Beyer, J. L. (2013). Mood Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370016.mt05
449. Stegner, A. J., Shields, M. R., Meyer, J. D., & Cook, D. B. (2013). Physical Activity, Stress Reactivity, and Stress-Mediated Pathophysiology. Routledge eBooks. https://doi.org/10.4324/9780203132678-34
450. Steinert, C., Heim, N., & Leichsenring, F. (2021). Procrastination, Perfectionism, and Other Work-Related Mental Problems: Prevalence, Types, Assessment, and Treatment—A Scoping Review. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2021.736776
451. Stewart, S. M. (2013). Depression. The Encyclopedia of Cross‐Cultural Psychology. https://doi.org/10.1002/9781118339893.wbeccp158
452. Stoller, K. B. (2015). Psychiatric Co-occurring Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190214647.003.0015
453. Stone, J., Carson, A., & Sharpe, M. (2005). Functional symptoms in neurology: management. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2004.061663
454. Strain, J. J., Klipstein, K., & Newcorn, J. H. (2008). Adjustment Disorders. Psychiatry. https://doi.org/10.1002/9780470515167.ch81
455. Strosahl, K. D. (2022). ACT con el paciente multiproblemático. ABA España eBooks. https://doi.org/10.26741/978-84-09-43990-4_09
456. Sugimoto, A., Futamura, A., & Kawamura, M. (2013). [Epilepsy and cognitive dysfunction].. PubMed.
457. Sun, Y., Zhang, Z., & Liu, X. (2016). Orosomucoid (<scp>ORM</scp>) as a Potential Biomarker for the Diagnosis of Chronic Fatigue Syndrome (<scp>CFS</scp>). CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.12522
458. Sung, H. C., & Chang, A. B. (2010). The effectiveness of preferred or familiar music listening on behavioural and psychological symptoms of institutionalised older adults with dementia: a systematic review. JBI Library of Systematic Reviews. https://doi.org/10.11124/jbisrir-2010-726
459. Sung, H. C., & Chang, A. B. (2010). The effectiveness of preferred or familiar music listening on behavioural and psychological symptoms of institutionalised older adults with dementia: a systematic review. The JBI Database of Systematic Reviews and Implementation Reports. https://doi.org/10.11124/01938924-201008341-00020
460. Szkodny, L. E., Jacobson, N. C., Llera, S. J., & Newman, M. G. (2014). Generalized Anxiety Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg19
461. Tahmazov, E., Robert, G., Walter, M., & Lemey, C. (2021). Anxiety in depression. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.1831
462. Tanaka, M., Tajima, S., Mizuno, K., Ishii, A., Konishi, Y., Miike, T., & Watanabe, Y. (2015). Frontier studies on fatigue, autonomic nerve dysfunction, and sleep-rhythm disorder. The Journal of Physiological Sciences. https://doi.org/10.1007/s12576-015-0399-y
463. Tang‐Wai, D. F., Josephs, K. A., & Petersen, R. C. (2005). Alzheimer's disease: overview. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544873.029
464. Tareen, A., Garralda, M. E., & Hodes, M. (2007). Post-traumatic stress disorder in childhood. Archives of Disease in Childhood Education & Practice. https://doi.org/10.1136/adc.2006.100305
465. Taylor, M. E., & Whitney, J. (2021). Impaired Cognition and Falls. Cambridge University Press eBooks. https://doi.org/10.1017/9781108594455.009
466. Thakur, A., Choudhary, D., Kumar, B., & Chaudhary, A. (2021). A Review on Post-traumatic Stress Disorder (PTSD): Symptoms, Therapies and Recent Case Studies. Current Molecular Pharmacology. https://doi.org/10.2174/1874467214666210525160944
467. Timperley, J., Leeson, P., Mitchell, A. R., & Betts, T. (2007). Chapter 6 Troubleshooting pacemakers. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198571322.003.0006
468. Tollefson, G. D., Souêtre, E., Thomander, L., & Potvin, J. H. (1993). Comorbid anxious signs and symptoms in major depression. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199300840-00013
469. Tom, N. R., Varghese, G. H., Lakshmi, S., & Sivakumar, T. (2014). Pre Menstrual Syndrome: Different Approaches of Management.
470. Tong, G., Groom, K. N., Ward, L., & Naeem, M. Y. (2021). “This Is Not the Original Timeline”: A Case Report of an Extended Dissociative Episode in a Healthy Young Male Accompanied with Severe Decline in Mental State. Case Reports in Psychiatry. https://doi.org/10.1155/2021/6619579
471. Tonge, B. J. (2013). Principles for managing attention deficit hyperactivity disorder. Australian Prescriber. https://doi.org/10.18773/austprescr.2013.064
472. Townsend, M. C. (2004). Nursing diagnoses in psychiatric nursing : care plans and psychotropic medications. F.A. Davis Co. eBooks.
473. Treacy, C. (2015). How does multiple trauma, traumatic brain injury (TBI) or spinal cord injury (SCI) affect male sexual functioning?.
474. Treanor, M., & Roemer, L. (2010). Generalized Anxiety Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0379
475. Trill, M. D. (2013). Anxiety and sleep disorders in cancer patients. European Journal of Cancer Supplements. https://doi.org/10.1016/j.ejcsup.2013.07.009
476. Tuovinen, S., Lahti‐Pulkkinen, M., Girchenko, P., Heinonen, K., Lahti, J., Reynolds, R. M., Hämäläinen, E., Villa, P., Kajantie, E., Laivuori, H., & Räikkönen, K. (2020). Maternal antenatal stress and mental and behavioral disorders in their children. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2020.09.063
477. Uppal, T., Amarasekara, C., & Kaushik, V. (2011). Chronic pelvic pain. Australasian Journal of Ultrasound in Medicine. https://doi.org/10.1002/j.2205-0140.2011.tb00182.x
478. V.I., B., Spirin, I. A., & E.D., K. (2022). PSYCHOLOGICAL AND MEDICAL SAFETY OF PERSONNEL ON SHIPS AND EDUCATION OF SPECIALISTS IN MARINE MEDICINE. “Educational bulletin “Consciousness”. https://doi.org/10.26787/nydha-2686-6846-2022-24-7-12-21
479. Valdéz, P. (2018). Homeostatic and circadian regulation of cognitive performance. Biological Rhythm Research. https://doi.org/10.1080/09291016.2018.1491271
480. Valente, S. M. (1996). Diagnosis and Treatment of Panic Disorder and Generalized Anxiety in Primary Care. The Nurse Practitioner. https://doi.org/10.1097/00006205-199608000-00004
481. Vanin, J. R. (2008). Brief Psychiatric History and Mental Status Examination. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-263-2_2
482. Vanin, J. R. (2008). Overview of Anxiety and the Anxiety Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-263-2_1
483. Veen, D. C. V. D. (2021). Anxiety in late-life depression. https://doi.org/10.33612/diss.179793202
484. Vigueras, P., Vigueras, J. P., Meca, R. L., Fernández, P. R., Retuerto, B. M., González, J. G., & Gaspar, J. C. (2011). La crisis económica y las urgencias hospitalarias generales y psiquiátricas. Puesta al día en urgencias, emergencias y catástrofes.
485. Vilibić, M., Jukić, V., Vidović, A., & Brečić, P. (2013). Cobalamin deficiency manifested with seizures, mood oscillations, psychotic features and reversible dementia in the absence of typical neurologic and hematologic signs and symptoms: a case report.. PubMed.
486. Vinkers, C. H., Kuzminskaite, E., Lamers, F., Giltay, E. J., & Penninx, B. W. (2021). An integrated approach to understand biological stress system dysregulation across depressive and anxiety disorders. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2021.01.051
487. Vuppalapati, C., Kedari, S., Ilapakurti, A., Kedari, S., & Shankar, J. (2019). Emotional Health: A Data Driven Approach to Understand our Emotions and Improve our Health. https://doi.org/10.1109/cse/euc.2019.00071
488. Víu, C. M. D., & Blasco, J. M. (2011). Salud laboral y salud mental: estado de la cuestión. Medicina y Seguridad del Trabajo. https://doi.org/10.4321/s0465-546x2011000500001
489. Wadhwa, R., & Khandare, M. (2014). Stress Management through Yoga. Global Journal of Human-Social Science.
490. Wakefield, J. C. (2015). DSM-5 substance use disorder: how conceptual missteps weakened the foundations of the addictive disorders field. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.12446
491. Wakefield, J. C., & Schmitz, M. F. (2014). Uncomplicated depression is normal sadness, not depressive disorder: further evidence from the NESARC. World Psychiatry. https://doi.org/10.1002/wps.20155
492. Walder, D. J., Statucka, M., Daly, M., & Yaffe, B. (2014). Psychotic Disorders. Psychology. https://doi.org/10.1093/obo/9780199828340-0151
493. Wardani, R. A., Arismawati, D. F., & Mayasari, B. (2021). Latihan Senam Yoga Pada Lansia Untuk Mencegah Depresi Pada Penderita Diabetes Melitus Di Posyandu Lansia Desa Sooko Kecamatan Sooko Kabupaten Mojokerto. https://doi.org/10.30994/jceh.v4i1.124
494. Ware, W. A., Bonagura, J. D., & Scansen, B. A. (2021). Exercise Intolerance. CRC Press eBooks. https://doi.org/10.1201/9780429186639-9
495. Weems, C. F. (2019). The importance of the post-disaster context in fostering human resilience. The Lancet Planetary Health. https://doi.org/10.1016/s2542-5196(19)30014-2
496. Wei, L., Benhui, S., Lanping, J., & Xiaolin, T. (2014). The Impact of Health Education or Health of the Victims of the Earthquake in Disaster Area. Advances in Social Science, Education and Humanities Research/Advances in social science, education and humanities research. https://doi.org/10.2991/asshm-14.2014.7
497. Weibert, E., & Stengel, A. (2019). Die Rolle Der Psychotherapie Beim Reizdarmsyndrom. PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie. https://doi.org/10.1055/a-0829-6990
498. Westby, A., & Coburn-Pierce, M. (2018). Autism spectrum disorder in primary care. The Nurse Practitioner. https://doi.org/10.1097/01.npr.0000530326.85465.8b
499. Willroth, E. C., James, B. D., Graham, E. K., Kapasi, A., Bennett, D. A., & Mroczek, D. K. (2022). Well-being and Cognitive Resilience to Dementia-related Neuropathology. https://doi.org/10.31234/osf.io/sbh85
500. Wimalawansa, S. J. (2013). Causes and Risk Factors for Post-Traumatic Stress Disorder: The Importance of Right Diagnosis and Treatment. Asian Journal of Medical Sciences. https://doi.org/10.3126/ajms.v5i2.8537
501. Wimalawansa, S. J. (2013). Causes and Risk Factors for Post-Traumatic Stress Disorder: The Importance of Right Diagnosis and Treatment. Asian Journal of Medical Sciences. https://doi.org/10.71152/ajms.v5i2.3318
502. Winkelmann, C., & Schreiber, T. (2019). Using ’White Flags’ to categorize socio-cultural aspects in chronic pain. European Journal of Public Health. https://doi.org/10.1093/eurpub/ckz186.196
503. Winters, K. C., & Ingwalson, A. (2022). Internalizing and Related Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190678487.003.0006
504. Wirz‐Justice, A. (2003). Chronobiology and mood disorders. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2003.5.4/awirzjustice
505. Woo, B. K. (2011). Unrecognized medical disorders among older patients in psychiatric emergency service. International Journal of Geriatric Psychiatry. https://doi.org/10.1002/gps.2673
506. Woo, C. H., & Kim, S. (2014). Effectiveness of the Military Mental Health Promotion Program. Journal of Korean Academy of Nursing. https://doi.org/10.4040/jkan.2014.44.6.717
507. Xiao, J., Chan, C. W., & Chow, K. M. (2019). LIVING WITH DIGNITY AMONG CHINESE CANCER PATIENTS UNDERGOING CHEMOTHERAPY: A QUALITATIVE STUDY. https://doi.org/10.26226/morressier.5cdbe0ab618793e647b12cfb
508. Yadin, E., & Foa, E. B. (2007). Cognitive Behavioral Treatments for Posttraumatic Stress Disorder. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511500008.013
509. Yang, B.-K., Yi, S.-R., Ahn, Y.-J., Im, S. H., & Park, S. H. (2016). Ischial Tuberosity Avulsion Stress Fracture after Short Period of Repetitive Training. Hip & Pelvis. https://doi.org/10.5371/hp.2016.28.3.187
510. Yarlagadda, A. R., Brown, A. B., & Clayton, A. H. (2007). Onset of Obstructive Sleep Apnea After Initiation of Psychotropic Agents. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0611h
511. Young, C., & Horton, J. (2019). Canine and Equine Therapy for Mental Health: A Review of Clinical Effectiveness [Internet].
512. Yudofsky, S. C., Silver, J., & Anderson, K. (2013). Aggressive Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625154.da10
513. Zutshi, A., Math, S. B., & Reddy, Y. C. J. (2007). Escitalopram in Obsessive-Compulsive Disorder. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0611c
514. Šostar, Z., Vodanović, M., Breitenfeld, D., Breitenfeld, T., Buljan, D., & Granić, R. (2009). Composers - Substance Abusers. Alcoholism and psychiatry research Journal on psychiatric research and addictions.